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ABSTRACT 
VALIDATION OF HAND-HELD BIOELECTRICAL IMPEDANCE ANALYSIS FOR THE 
ASSESSMENT OF BODY FAT IN YOUNG AND OLD ADULTS 
 
by 
 
Lynn Wheeler 
 
The University of Wisconsin-Milwaukee, 2012 
Under the Supervision of Ann M. Swartz, Ph.D. 
 
 
 
Because of health concerns surrounding overweight and obesity, many 
individuals, health clubs, and physicians have begun using portable measures of body fat 
(BF) that are inexpensive and easy-to-use. Based on measures from these devices, 
health-related decisions are made and progress during fitness and/or dietary programs 
is tracked. However, accuracy of portable BF devices can be questionable, especially in 
free-living settings. Purpose: The purpose of this study is to evaluate the validity and 
reliability of a commercially-available, hand-held bioelectrical impedance analysis (BIA) 
device as a measure of BF during a controlled laboratory condition and a free-living 
condition. Methods:  A total of 91 White individuals (41 men, 50 women), ages 19-39 
(young group) and 55-75 years (old group), completed the study. During the laboratory 
visit, body fat measures from the hand-held BIA and to two additional methods, DEXA 
and tetrapolar BIA, were compared across age and sex when pre-testing guidelines were 
followed.  Participants were then asked to take the hand-held BIA home to complete 
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four free-living BF% measures.  A mixed between by within design comparing sex and 
age groups (between groups variables) across hand-held BIA, tetrapolar BIA and DEXA 
measurements (within groups variable) was performed to determine whether 
differences among body fat assessment devices exist.  Post-hoc planned comparisons 
were performed to determine which devices are different in assessing BF among the 
hand-held BIA, the tetrapolar BIA and the DEXA.  Repeated-measures ANOVA with post 
hoc comparisons were performed to determine differences in BF measures among 
hand-held BF measures over the free-living day. Results: BF results from the hand-held 
BIA were significant from DEXA and tetrapolar BIA for the female and young groups. 
Specifically in the female group, the hand-held BIA underestimated %BF by 2.7 
percentage points compared to the DEXA.  The tetrapolar BIA also underestimated %BF 
by 2.5 percentage points compared to the DEXA.  In the young group, the hand-held BIA 
underestimated %BF by 3.5 percentage points compared to the DEXA.  The tetrapolar 
BIA also underestimated %BF by 3.8 percentage points compared to the DEXA.  In the 
male and old groups, there was no significant difference between BF measures from 
DEXA and hand-held BIA, but significant differences were present between the 
tetrapolar BIA and hand-held BIA.  The hand-held BIA overestimated %BF by 2.6 and 1.9 
percentage points in the male and old groups, respectively, as compared to the 
tetrapolar BIA.  Despite the fact that there were statistically significant differences in BF 
measures from the hand-held BIA and the DEXA, these differences did not exceed the 
clinically acceptable level (±3.5%).  Conclusion: The hand-held BIA device is designed for 
use by individuals to assess BF level.  Although means were not clinically different 
iv 
 
between the hand-held device and DEXA in all groups, difference scores between 
devices suggest that the hand-held BIA is not a valid device on an individual level and, 
therefore, not recommended for the assessment of %BF.  
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Chapter 1: Introduction 
 
Background 
The prevalence of overweight and obesity is high in the United States and other 
industrialized nations throughout the world.  Based on self-report weight and height 
information, data from the 2007-2008 National Health and Nutrition Examination 
Survey (NHANES)— a nationally representative sample of U.S. adults— demonstrated 
that 34% of adults aged 20 years and older are overweight, 34% are obese, and 6% are 
extremely obese with the remaining 26% being classified as normal BMI (Flegal, Carroll, 
Ogden, & Curtin, 2010) .  Given the numerous health risks associated with being 
overweight or obese including coronary artery disease, diabetes mellitus, hypertension, 
hyperlipidemia, and certain types of cancer (Burton & Foster, 1985; Goodpaster et al., 
2005; Kaminsky, 2010; Must et al., 1999; Wagner & Heyward, 1999), physicians and 
other health practitioners are commonly recommending that their patients lose weight 
in order to reduce their body fat (BF) level.   
There are several methods for assessing body composition, but not all are 
feasible or affordable for use by individuals, fitness centers, or physicians.  Laboratory 
methods such as hydrostatic weighing (HW), air-displacement plethymography and 
dual-energy x-ray absorptiometry (DEXA) are commonly used and accurate tools for 
determining the body composition of various populations.  However, these devices and 
procedures are expensive, time-consuming, and require trained technicians, and thus 
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are not readily-available for use at home or in local fitness centers and clinics (Weaver, 
Hill, Andreacci, & Dixon, 2009).  In contrast, field devices to assess body composition are 
for the most part portable, relatively inexpensive, and often require less technician 
knowledge or skill.  Two popular field methods include skinfold measurements and 
segmental bioelectric impedance analysis (BIA).  However, these devices have been 
found to be less accurate in estimating body composition when compared to laboratory 
methods such as DEXA and HW (Duz, Kocak, & Korkusuz, 2009; Esco, Olson, Williford, 
Lizana, & Russell, 2011a).  
Many individuals have taken to self-monitoring body composition using portable, 
inexpensive assessment tools given physician recommendations or their own desire to 
reduce BF.  Individuals use information about their body composition to help them 
make health-related decisions (e.g., dietary or physical activity changes, medications, 
medical procedures) and to track progress of an exercise or diet program, or other 
health intervention (Heyward & Wagner, 2004).  Clinicians use body composition 
information to identify patients at greater risk for developing chronic acquired diseases 
such as cardiovascular disease or diabetes mellitus, diagnose individuals with metabolic 
syndrome, or monitor disease state progression (Wagner & Heyward, 1999).  Among 
athletes, there is an inverse relationship between increased percent body fat (%BF) and 
athletic performance in certain sports (Malina, 2007).  Consequently, monitoring %BF 
during an athletic training program becomes important for athletes to optimize 
performance.  Given that individuals, fitness centers, and physicians are using portable 
body composition assessment tools to guide health-related decisions and 
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recommendations, it is essential that tools used for assessing body composition outside 
of laboratory settings provide valid and reliable results (Weaver, et al., 2009). 
One example of a commercially-available, inexpensive device (approximately 50 
USD$, 2012) that is used by individuals, fitness centers, and physicians to measure body 
composition is the Omron HBF-306C (see Figure 1).  This is a portable and safe hand-
held BIA device that provides quick and easy estimates of %BF.  The Omron HBF-306C 
works by introducing a single frequency electrical current through electrodes implanted 
in the handles of the device.  The nature of this current is such that the subject being 
tested cannot detect it and  the impedance to the current flow from one hand to the 
other is determined (Lintsi, Kaarma, & Kull, 2004b).  The current will flow more rapidly 
through fat-free mass due to the larger water and electrolyte content of fat-free tissues.  
Greater impedance occurs when the current flows through adipose tissue which 
contains little water (Esco, Olson, Williford, Lizana, & Russell, 2011b).  
Given the Omron HBF-306C’s heavy reliance on water content within tissues, 
hydration status is critical to measures of impedance (Kaminsky, 2010).  Factors that can 
influence an individual’s hydration status include food and water consumption, use of 
diuretics, alcohol consumption and exercise.  The consumption of food and water will 
directly increase the amount of fluid in the body.  The use of diuretics will do exactly the 
opposite, increasing the excretion of water from the body through urination.  
Consumption of alcohol, a type of diuretic, will cause dehydration through increased 
urination.  Exercise can affect BIA readings in two ways: 1) loss of fluid from the body 
due to sweating, 2) increased blood flow to the skeletal muscle and skin which increases 
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heat and will decrease the impedance to the current (Dehghan & Merchant, 2008; 
Weaver, et al., 2009). Careful control of all of these variables does not always occur 
when using a hand-held BIA in a free-living situation.  
A small number of published studies have investigated the validity of hand-held 
BIA devices.  Results of these validation studies have been contradictory and, therefore, 
inconclusive.  Results have varied due to the populations studied and pre-testing 
conditions applied. In addition, most studies were performed under controlled 
conditions, limiting their external validity since these devices are commonly used in 
free-living situations. 
 
Figure 1.  Omron HBF-306C 
 
Research Question 
 Is the Omron HBF-306C hand-held body fat analyzer accurate in estimating 
percent body composition in both a controlled and free-living environment? 
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Statement of Purpose 
The purpose of this study was to evaluate the validity of a commercially-available 
hand-held bioelectrical impedance analysis device as a measure of body composition for 
adults in a controlled laboratory condition and during a free-living condition. 
Specific Aims 
Specific aim 1 was to compare body fat measures from the hand-held BIA to two 
additional methods used to estimate of body fat— DEXA and tetrapolar BIA— across 
age and sex when pre-testing guidelines were followed.   
Specific aim 2 was to examine the reliability of body fat estimates from a hand-
held BIA at four pre-determined times during one free–living day in the same 
population.  These four body fat estimates taken during the free-living day helped 
determine variations in body fat measures when pre-testing guidelines were not 
followed. 
 
Hypotheses 
It was hypothesized that BF results from the hand-held BIA would not 
significantly differ from the tetrapolar BIA and DEXA BF measures taken during the 
controlled laboratory condition.  However, significant variations in BF were expected 
during the free-living day demonstrating that, when pre-test instructions were not 
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followed, results would not be reliable and should not be used to make-health related 
decisions. 
 
Assumptions 
 There were three main assumptions for this study.  First, it was assumed that all 
participants were honest when answering screening questions to determine eligibility 
for study participation.  Second, it was assumed that all participants followed the pre-
testing guidelines prior to the first lab visit for the body composition assessments.  
Third, it was assumed that, during the free-living day, all participants followed the study 
instructions given to them at the first Laboratory visit, and were honest when recording 
their %BF from the hand-held BIA throughout the day.   
Delimitations 
 A delimitation to the current study was that the results are only generalizable to 
a population that is free of any disease or medication that can alter hydration status, 
White individuals, and individuals within similar age ranges used in the current study 
(18-39 and 55-75 years of age). 
 
Significance 
 To date, there has been little research on the validity of hand-held BIA devices 
for estimating %BF.  The results of this study will have both scientific and practical 
significance. 
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Scientific Significance 
Hand-held BIA devices are relatively new, commercially-available products.  Very 
little research has been conducted on their validity and reliability, specifically, the 
Omron HBF-306C device.  It is one of three hand-held BIA devices currently on the 
market for sale in 2012.  Of the previous research on validity and reliability of hand-held 
BIA devices, even less has been completed across a large age span.  Most of the 
previous studies have been completed using young adults, rarely including subjects over 
the age of 60.  This is important because of the changes in FM and FFM as adults age 
and it remains unknown if the hand-held BIA devices are appropriate for use acrossthe 
age spectrum.  Additionally, more research needs to be done on the accuracy and 
reliability across sex.  The absolute and relative fat mass and fat distribution differs 
between men and women, and it is important to determine if those differences impact 
the validity and/or reliability of the device in these populations.  It is, therefore, critical 
to validate this device across the two variables of age and sex.  Lastly, although the 
concept of euhydration is extremely important in the assessment of body composition 
with BIA devices, only one of the previous validation studies on hand-held BIA devices 
has controlled for hydration using all of the ACSM pre-testing guidelines.  This could be a 
major limitation to all of the validation studies previously conducted on hand-held BIA 
devices.  It is also important to compare the results of BF measures from the hand-held 
BIA device to the criterion measures in both a controlled setting when individuals are 
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euhydrated, and in a free-living environment when the pre-testing guidelines are not 
necessarily followed.   
 
Practical Significance 
 Because many individuals engage in the self-monitoring of body composition, 
and inexpensive, commercial devices are available to do so, it is important to make sure 
these devices are accurate in estimating %BF.  And also important, if the devices are 
accurate in both a controlled setting when pre-testing guidelines are followed or in a 
free-living situation where pre-testing guidelines are often not followed.  This becomes 
even more important when individuals are making health-related decisions in their own 
life, or someone else’s, based on results from the hand-held BIA devices.  There is a lack 
of literature available for the general public to understand how to properly use the 
hand-held BIA devices and how accurate they are when estimating %BF.   
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Chapter 2: Literature Review 
 
Introduction 
The prevalence of overweight and obesity is high in the United States and other 
industrialized nations throughout the world.  Based on self-report information, data 
from 2007-2008 National Health and Nutrition Examination Survey (NHANES) 
demonstrated that 34% of adults aged 20 years and older are overweight, 34% are 
obese, and 6% are extremely obese (Flegal, et al., 2010) based on body mass index 
(BMI) classifications.  Given the numerous health risks associated with being overweight 
or obese including coronary artery disease, diabetes mellitus, hypertension, 
hyperlipidemia, and certain types of cancer (Burton & Foster, 1985; Goodpaster, et al., 
2005; L.A. Kaminsky, 2010; Must, et al., 1999; Wagner & Heyward, 1999), physicians are 
commonly recommending that their patients lose weight and reduce their body fat (BF) 
level.   
Many individuals have taken to self-monitoring body composition given 
physician recommendations or their own desire to reduce BF, often using portable, 
inexpensive assessment tools.  Individuals use body composition results from these 
devices to help them make health-related decisions (dietary or physical activity changes, 
medications, medical procedures) and also use this information to track progress of an 
exercise or recommended diet program, or other health interventions (Heyward & 
Wagner, 2004).  Clinicians use body composition information to identify patients at 
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greater risk for developing cardiovascular disease or diabetes mellitus, to diagnose 
individuals with metabolic syndrome, or to monitor diseased state progression (Wagner 
& Heyward, 1999).  In athletes of certain sports, previous research suggests that there is 
an inverse relationship between increased %BF and athletic performance (Malina, 
2007).  Consequently, monitoring %BF during an athletic training program becomes 
important to optimize performance.  Given that individuals, fitness centers, and 
physicians are using portable body composition assessment tools to guide health-
related decisions and recommendations, it is essential that tools used for assessing body 
composition outside of laboratory settings are accurate (Weaver, et al., 2009). 
 
Body Composition 
Understanding that it is important to monitor and control BF from a health 
perspective, it is equally important to know that BF is only one part of a larger picture: 
total body composition.  Body composition includes all things that give mass, shape and 
function to living things, including elements, tissues and organs (Heymsfield, 2005).  
Knowledge of body composition comes mainly from chemical analysis of organs and 
cadavers (Heyward & Wagner, 2004).  Body composition is not just limited to %BF or fat 
mass (FM), depending on the number of compartments being assessed, total body 
composition can include estimates of fat free mass (FFM), lean body mass (LBM), 
mineral-free lean tissue, bone mineral content (BMC) and total body water (TBW) in 
addition to %BF or FM.  All are considered separate compartments of body composition.  
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Fat free mass and LBM have been used synonymously, but they are not the same.  “Fat 
free mass is all residual chemicals and tissues including water, muscle, bone, connective 
tissue and internal organs” (Heyward & Wagner, 2004, p.5).  Lean body mass is 
comprised of FFM plus essential lipids.   Mineral-free lean tissue is FFM minus BMC.  Fat 
mass is the most widely varied compartment accounting for anywhere between 6-60% 
of an individual’s total body weight (S.B. Heymsfield, Lohman, Wang, & Going, 2005).  
Fat mass is comprised of essential lipids and stored adipose tissue and is present in 
many areas of the body.  Subcutaneous fat lies just under the skin throughout the body.  
This is the type of FM that individuals can see and feel by pinching the skin and the 
underlying fat tissue.  There is also fat that is not measurable without the use of imaging 
techniques called visceral fat.  Visceral fat is located in the abdomen around the organs.  
Fat free can also be found in the yellow bone marrow in adults as well as within the 
muscule (intramuscular).  TBW is the sum of extracellular water (ECW) and intracellular 
water (ICW) (Kyle, Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et al., 2004).  The 
human body is made up approximately 62% water, depending on hydration level of the 
individual (Brozek, Grande, Anderson, & Keys, 1963) and the aqueous fraction of the fat-
free mass of the theoretical standard reference man is 73.8%.  Bone mineral content 
(BMC) is the amount of minerals per centimeter of bone (g/cm).  Furthermore, bone 
mineral density (BMD) is the ratio of BMC to bone size (g/cm²) and is commonly used as 
a marker for determining osteopenia and osteoporosis (Deng, Xu, Davies, Heaney, & 
Recker, 2002). 
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These compartments are then combined in different manners to create body 
composition models.  Body composition models can be broken into two, three, four, five 
or even six compartments.  These multicomponent models are defined by five specific 
levels of measuring body mass: atomic, molecular, cellular, tissue-organ and whole-body 
demonstrated in Figure 2 (Heyward, 1996).  However, the most commonly used level in 
exercise physiology is the tissue-organ level.  The tissue-organ level is made up of 
compartments of adipose tissue, skeletal muscle, visceral organs and bone.  A widely-
used two-compartment model includes measures of FM and FFM.  A common three-
compartment tissue-organ level model would be one that includes BMC, FM and 
Mineral-free lean tissue.  A benefit to using this three compartment model is that there 
is no assumption in the hydration of FFM and therefore dismisses that variation 
between individuals (Withers et al., 1998).  Another common three-compartment model 
is one that consists of TBW, FM and FFM.  And a common four-compartment model 
would include BMC, FM, FFM and TBW.  A four compartment model is considered most 
valid because it controls for variability between individuals in both BMD and TBW 
(Withers, et al., 1998), however, increasing the number of measure could also introduce 
more room for error.  
The whole-body level utilizes anthropometric measures, not necessarily specific 
compartments.  This would include measures of height, weight and circumferences.   
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Figure 2.  Five levels of measuring body mass.  Adapted from Wang, Pierson & 
Heymsfield (1992) 
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Factors Impacting Body Composition 
For all individuals, there are modifiable and non-modifiable factors in 
determining one’s body composition.  Body composition can vary greatly across age, 
sex, stature and race, all of which are non-modifiable.  As adults age, there is usually an 
increase in FM, until about age 74, and then FM begins to decrease slightly (Kyle et al., 
2001).  Additionally, older adults experience a decline in FFM, mainly due to loss of bone 
mineral and skeletal muscle mass (Heyward & Wagner, 2004).  This decrease in skeletal 
muscle, or sarcopenia, generally occurs after the age of 30-40 years and is heightened 
after the age of 60 years (Kyle, et al., 2001).  The decline in skeletal muscle in older 
adults has been noted to be higher in men than women (Gallagher et al., 1997).  The 
resulting age-related sarcopenia is associated with atrophy of muscle fibers, which may 
occur due to a decline in α-motor neurons, growth hormone production, sex steroid 
levels and physical activity (Thomas, 2007).  Finally, research has shown that as adults 
age, there is an increase in waist circumference in both men and women, without an 
increase in weight (Stevens, Katz, & Huxley, 2010).  This can be due to increased 
abdominal adiposity in combination with overall sarcopenia.  This increase in waist 
circumference and abdominal adiposity can increase the risk of chronic disease such as 
cardiovascular disease and type 2 diabetes, associated with premature death (Janssen, 
Heymsfield, Allison, Kotler, & Ross, 2002; Snijder, van Dam, Visser, & Seidell, 2006) .    
There are also differences in body composition between the sexes.  Typically, 
men have more FFM and less FM as compared to women (Baumgartner, 2000; Janssen, 
Heymsfield, Wang, & Ross, 2000a).  Janssen and colleagues (2000) found that men, on 
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average, have 36% more skeletal muscle than women.  However, the rate of decrease in 
skeletal muscle after the age of 45 years is greater among men than among women.  It 
has been found that women tend to have higher levels of subcutaneous fat when 
compared to men (Enzi et al., 1986).  This higher level of body fat is necessary for 
reproductive processes.  Also, body fat distribution may vary between sexs: men tend to 
carry more FM in the android region and women tend to carry more FM in the gynoid 
region (Stevens, et al., 2010).  On average, women are also more likely to have lower 
bone density than men over a span of 18-80 years (Russo et al., 2003; Warming, 
Hassager, & Christiansen, 2002).  In addition, women typically experience a dramatic 
decrease in BMC and BMD during the perimenopausal and early postmenopausal years 
due to the decline in endogenous estrogen, which aids in preserving bone density 
(Lindsay, 1996).  On the other hand, men tend to have higher bone mineral density 
because of testosterone until about the age of 50 (Wishart, Need, Horowitz, Morris, & 
Nordin, 1995).  However, as men age, their levels of testosterone decrease and BMD 
declines (Snyder et al., 1999).  The rate of decrease in bone mineral density is greater in 
women immediately after menopause, but the rate in men and women is the same once 
adults reach about 65-70 years of age (National Institutes of Health Osteoporosis and 
Related Bone Diseases, 2011). 
Other than sex and age differences in body composition, there are also 
differences in body composition between races.  Wagner and Heyward (Wagner & 
Heyward, 2000) stated that African Americans, on average, have higher bone mineral 
density and higher muscle mass than Whites.  Barondess and colleagues (Barondess, 
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Nelson, & Schlaen, 1997) conducted a study with black and white men to compare bone 
mineral density.  They discovered that the black men had a higher BMD (1.25 g/cm²) 
than the white men (1.16 g/cm²).  In 2001, Casas, Shiller, DeSouza and Seals (Casas, 
Schiller, DeSouza, & Seals, 2001) found Hispanic women to have higher percent body 
fat, total fat mass and BMI as compared to their White counterparts.  Wulan, 
Westerterp and Plasqui (2009) found that Asians have higher body fat percentage 
compared to Whites.  Furthermore, there were also differences in body fat percent 
between regions of Asia (Asian Indians, Malay, and Chinese).   
In addition to the non-modifiable factors that can affect body composition, there 
are modifiable factors that can affect body composition: lifestyle and disease state 
(Crawford et al., 1994; Rippe & Hess, 1998).  These factors can be acute or long-term.  
Acute factors could include hydration status and/or the use of diet or weight loss 
medication. Long-term factors include physical activity, diet and weight loss surgery.  
Increases in physical activity have the potential to increase FFM and decrease FM (Rippe 
& Hess, 1998; Stiegler & Cunliffe, 2006).  In contrast, decreases in physical activity can 
lead to losses in FFM and increase in FM (Boonyarom & Inui, 2006).  Diet has the ability 
to alter FFM and FM.  High protein diets can potentially increase the amount of skeletal 
muscle mass or FFM (Rasmussen et al., 2000).  Changes in diet can also increase or 
decrease the amount of FM.  A substantial chronic decrease in calorie consumption can 
lead to a decrease in FM.  Conversely, a chronic increase in calorie consumption can 
increase the total amount of FM.  Weight loss surgery is also an acute and long-term 
method of changing body composition for morbidly obese individuals.  Most often, 
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weight loss surgeries will restrict the amount of food intake by the individual both 
before and as a result of surgery, hence decreasing calories consumed daily (Kenler, 
Brolin, & Cody, 1990).  Therefore, the individual will lose FM and maintain or potentially 
decrease FFM because there is less body mass for the individual to carry around (Chao 
et al., 2000; Weiss et al., 2007). 
 
Methods to Estimate Body Composition 
This section will include a detailed review of the most common methods used to 
assess body composition, specifically focusing on 1) the outcome measure of the body 
composition assessment method, 2) how the method works, 3) assumptions, 4) special 
considerations (participant preparation, risks, etc.) 5) validity and reliability, 6) 
advantages and disadvantages.  For discussion purposes, field-based methods will be 
addressed first, then laboratory methods.  
 
Field-Based Methods 
A field-based method for assessing body composition is one that can be used in 
many different locations and not restricted to use in a laboratory or clinical setting.  
While numerous body composition assessment methods are available, the following 
field-based methods will be discussed in this section: BMI, skinfold measures and 
bioelectrical impedance analysis (BIA).  There are many common advantages to all of the 
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field-based methods for assessing body composition.  First, most field devices are 
portable making them easy to use at home or in fitness centers and clinics.  Second, the 
majority of these methods are cost-efficient.  The low cost makes these devices more 
available more accessible to individuals and groups.  Field devices generally require 
relatively little technician skill or knowledge to operate.  Although many field devices 
have been created and are usually validated with laboratory methods, previous research 
has demonstrated that most field devices are less accurate and reliable than laboratory 
methods (Duz, et al., 2009).   
Body mass index (BMI) is an anthropometric method that is used to estimate 
obesity.  BMI is calculated as a ratio of height and mass (kg/m²).  Based on the results of 
this calculation, individuals are then classified as underweight, normal BMI, overweight 
or obese. Underweight BMI is defined as a BMI of 18.4 kg/m² or lower, normal BMI is 
defined as a BMI of 18.5-24.9 kg/m², overweight is defined as a BMI of 25.0-29.9 kg/m² 
and obese is defined as a BMI of 30.0kg/m² or more (L.A. Kaminsky, 2010; National 
Institutes of Health, 1998).  The main assumption of BMI is that there are no differences 
between age and sex when designating adults into obesity categories (Gallagher et al., 
1996b).  There are many advantages to using BMI to classify level of obesity. It is cost 
effective requiring minimal equipment, there is no necessary participant compliance 
prior to taking measures, there is no risk to the participant, and it is a fast and easy 
measurement and calculation, requiring minimal technician experience.  However, there 
are some major drawbacks to using BMI.  It does not take into account regional fat 
distribution, muscle mass or bone mineral density and therefore may misclassify 
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individuals into the categories of underweight, normal weight, overweight or obese 
(Burton & Foster, 1985; Nevill, Stewart, Olds, & Holder, 2006; Romero-Corral et al., 
2008).  For example, an individual could have a normal BMI, but still be classified as 
overweight or lean based on estimations of %BF.  This misclassification occurs due to 
the known differences in mass between adipose tissue, muscle tissue, as well as the 
individual’s bone mineral density.  Muscle tissue is more dense than adipose tissue, 1.34 
g/cm³ and 0.9 g/cm respectively (Brozek, et al., 1963).  Therefore, an individual with 
more muscle mass will have a greater body mass, all other things equal.  Likewise, an 
individual that has higher bone mineral content will have greater body mass, all things 
being equal.  Consequently, an individual such as a body builder or an athlete with more 
muscle mass or higher bone mineral density than the average adult, may be 
misclassified as overweight because of the additional mass of the muscle tissue and 
bone (Nevill, et al., 2006).  They may be misclassified as overweight or even obese by 
BMI, however based on a body composition measure, they may be considered lean or 
normal.  On the other hand, individuals with low muscle mass and high levels of fat can 
also be misclassified (Kennedy, Shea, & Sun, 2009).  For example, as adults age, they 
gain more adipose tissue and lose muscle mass, perhaps being classified as having a 
normal BMI however, may actually be overweight or obese based on a body 
composition measure (Kyle, et al., 2001).  Many studies have assessed the validity of 
BMI as an indicator of obesity.  Gallagher and colleagues (Gallagher et al., 1996a) found 
that when they compared young and old adults with the same BMI, that the older adults 
actually had a higher %BF indicating misclassification of obesity level.  Similarly, they 
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found that BMI cannot be used when comparing obesity level between men and women 
because women, on average, have a higher %BF than men.  Additionally, Kennedy and 
colleagues (Kennedy, et al., 2009) found that there was a large discrepancy between 
obesity level classified by BMI and that estimated from DEXA.  They suggested that using 
BMI as a classification of obesity level should be viewed with caution because it may 
misclassify some individuals and therefore ignore the possibility of health interventions 
that may be necessary.  In conclusion, BMI is widely used as a broad indicator of obesity 
in large epidemiological studies, but is discouraged for use in small scale studies and for 
clinical diagnosis of obesity (Kennedy, et al., 2009). 
Skinfold measures are a two-compartment model for body composition 
assessment providing estimates of FM and FFM.  This method is based on the 
assumption that “subcutaneous fat in a particular skinfold is proportional to the total 
amount of overall body fat” (Kaminsky, 2010, p.62).  Lohman estimated that one-third 
of the human body is made up of subcutaneous fat (T.G. Lohman, 1981).  Secondly, it 
assumes that a skinfold is a good measure of subcutaneous fat (T.G. Lohman, 1981).  
Additionally, it assumes that water and mineral content is the same in all individuals 
(Lintsi, et al., 2004b).  The technician pinches a fold of skin while only taking the 
subcutaneous fat and skin, not muscle tissue.  A caliper then measures the thickness of 
the fold that includes skin and subcutaneous fat.  Based on the amount of sites used to 
measure skinfolds (as well as an individual’s race and sex), prediction formulas are then 
used to estimate body density and %BF (L.A. Kaminsky, 2010).  The accuracy and 
reliability for the skinfold technique in estimating BF depends on the skill of the 
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technician, the selection of sites to administer the skinfold measure, the size of the 
individual being measured and also the prediction formula used.  Linsti and colleagues 
(Lintsi, et al., 2004b) found that, when compared to DEXA, there were significant 
differences in skinfold estimates of BF with the Durnin & Womersley skinfold equation 
but no significant different when using the Deurenberg et al. skinfold equation. Duz and 
colleagues (Duz, et al., 2009) found that, when using the Jackson and Pollock (1978) and 
Jackson et al. (1980) prediction equations, skinfold measures (12.4±5.5% for males, 
20.8±1.0% for females) significantly underestimated BF estimations when compared to 
DEXA (18.5±6.2% for males, 28.4±1.3% for females).  In order to have proper skinfold 
thickness measures, calibration of skin calipers is important.  Gore and colleagues (Gore, 
Woolford, & Carlyon, 1995) determined that springs in the calipers need to be tested 
regularly to avoid fatiguing of the springs and, thus, allowing for less compression of the 
caliper jaw.  Although skinfold method is portable, inexpensive and quick, it still requires 
a trained technician to obtain measurements.   
 On the other hand, segmental BIA devices are easy to use and require no 
training to operate.  These devices are portable and can be used in many locations for a 
low cost.  Segmental BIA will be discussed further in the BIA Technology section. 
 
Laboratory-Based Methods 
Laboratory-based methods for assessing body composition are often large, non-
portable methods.  There are common advantages to laboratory-based methods for 
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assessing body composition.  First, a majority these methods have demonstrated great 
accuracy and have been validated against cadaveric analysis (because exact 
measurements can’t be done in vivo) for use in laboratory and clinical settings by 
previous research (Erceg et al., 2010).  Second, most, but not all, procedures using 
laboratory techniques are relatively quick.  There are common disadvantages associated 
with laboratory-based techniques.  The majority of these methods require costly 
equipment, ranging from as little as USD$5,000 up to millions of dollars, resulting in 
many of these methods being inaccessible for most clinicians, researchers and the 
public.  In addition to being costly, most of the equipment is generally large and not 
portable.  Lastly, almost all methods require a trained and knowledgeable technician to 
operate the equipment and analyze results.  Dual-energy x-ray absorptiometry (DEXA), 
hydrostatic weighing (HW), air displacement plethysmography (ADP), and tetrapolar 
bioelectrical impedance analysis (BIA) are all commonly used laboratory methods for 
body composition analysis that will be discussed in the following paragraphs.   
Originally created for assessing bone mineral composition for older adult 
females, DEXA has recently been considered a gold standard in assessing body 
composition.  DEXA assesses three compartments of the body: bone mineral content 
(BMC), mineral-free lean mass and FM.  Mineral-free lean mass, FM and BMC are 
estimated based on the tissue attenuation of two different energies (Pietrobelli, 
Formica, Wang, & Heymsfield, 1996).  The x-ray beams pass from the posterior to 
anterior of the body to a detector that is above the participant (Duz, et al., 2009).  Based 
on the attenuation, and known densities of FM and FFM, the three compartments can 
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be distinguished.  DEXA has, in recent years, been considered a gold standard method 
for assessing body composition because previous research has shown it to be both valid 
and reliable (Heyward, 1996).  Pritchard, Nowson, Strauss, Carlson, Kaymakci and Wark 
(1993) found that DEXA had greater precision when estimating fat mass when compared 
to HW, with a coefficient of variability of 1.8% for percent body fat and 2.1% for fat 
mass.  Lohman, Tallroth, Kettunen and Marttinen (Lohman, Tallroth, Kettunen, 
Marttinen, 2009) conducted reliability a study using the Lunar Prodigy densitometer.  
They found total body DEXA measures to be repeatable for LM (r=0.99), FM (r=1.00) and 
BMD (r=1.00).  DEXA is a quick, safe, can be used on almost all populations, and requires 
little pre-testing guidelines to be followed by the individual (Heymsfield, et al., 2005; 
Heyward, 1996).  There are disadvantages to using DEXA to assess body composition.  
Because DEXA is an x-ray device, participants will be exposed to small amounts of 
radiation.  The device being used for this study emits approximately 0.00004 mRem of 
radiation which is similar to a cross-country flight and is fractions less than the amount 
of radiation from a typical x-ray, such as a chest x-ray.  Therefore, it is considered safe 
for almost all populations (T. G. Lohman, 2005).   Because of the size of the Lunar 
Prodigy table, there are usage restrictions based on a participant’s size.  The total table 
size is 262cm long and 89cm wide, however, the area for scan is much smaller.  
Individuals that are taller than 193cm and wider than 60cm, will not receive accurate 
assessments as their entire body will not fit within the scan area.  The weight limit for 
the device is 159.0 kg, limiting usage to those weighing at or less than that amount.  
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DEXA is an expensive and non-portable device, and therefore may not be available for 
use by all individuals. 
Hydrostatic weighing (HW) has been considered a gold standard by some experts 
in the field and has been used as a criterion method in validating new body composition 
assessment methods (S.B. Heymsfield, et al., 2005; Heyward, 1996).  HW estimates body 
composition in two compartments—FFM and FM— by first measuring body volume, 
then body density is determined mathematically by dividing body mass by body volume 
(S.B. Heymsfield, et al., 2005).  HW estimates body volume by using Archimedes 
principle “that a body immersed in a fluid is acted on by a buoyancy force, which is 
evidenced by a ‘loss’ of weight and equal to the weight of the displaced fluid” (S.B. 
Heymsfield, et al., 2005), p. 19).  Individuals are submerged under water while under 
water mass or water displacement is measured.  Measures of body volume are 
corrected for residual air in the lungs and in the gastrointestinal tract.  There are four 
main assumptions for HW:  the components of the fat and FFM are known and additive; 
that the density of all tissues is constant for all individuals: lean body mass (FFM and 
bone) and FM; the proportions of water, mineral and protein comprising the FFM are 
constant within and between individuals; and the individual being measured differs 
from the reference body only in the amount of BF or adipose tissue (Heyward & 
Wagner, 2004) p. 8).  There are advantages to using HW to assess body composition.  
The method has been demonstrated as accurate.  Additionally, a water tank is not 
necessarily needed.  The procedure can be done in any pool, of proper depth for 
complete submersion, which can be accessed.  However, there are disadvantages to 
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using this technique due to the fact that there are more practical techniques available 
for assessing body composition.  One disadvantage is that the technique relies on the 
three assumptions stated earlier.  These assumptions will not always be met due to 
differences in composition of the different tissues that were discussed in the section 
Factors Affecting Body Composition earlier in the chapter.  Second, there is a great 
amount of participant compliance required for accurate measurement.  Participants 
should follow specific pre-testing guidelines (Heyward & Wagner, 2004) prior to the 
test.  Additionally, the technique itself requires a lot of participant compliance, and may 
be impossible for some participants to do.  For example, some individuals may not be 
able to correctly position their body, exhale completely when under water, or remain 
still while under water (Wagner, Heyward, & Gibson, 2000).  Moreover, the procedure is 
done multiple times until three trials are within 100g of each other (Wagner & Heyward, 
1999) are achieved.  Therefore, the procedure can be very time consuming (Wagner, et 
al., 2000).  Lastly, a great deal of technician knowledge and skill is required to complete 
the procedure.  It is more difficult to find validity and reliability information on HW 
because it is often used as a criterion measure for other methods for assessing body 
composition.   
Air Displacement Plethysmography (ADP) employs a two-compartment model to 
assess  body composition, very similar to HW, that first measures body volume and 
calculates body density with air displacement instead of water displacement (Heyward 
& Wagner, 2004).  Volume is measured using Poisson’s law, a variation of Boyle’s law 
that accounts for adiabatic conditions, in an enclosed chamber.  The only commercially 
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available ADP device is the BodPod (Fields, Goran, & McCrory, 2002).  While inside of 
the BodPod, small pressure changes determine the air displacement of the body, and 
therefore, body volume is measured.  Because body volume is being measured, 
measurements are taken for lung volume to estimate the most accurate total body 
volume.  Body fat percent is then calculated from body density via the same conversion 
formulas as HW.  There are many assumptions when assessing body composition with 
the ADP method.  First, because the BodPod device is measuring body volume, all of the 
four main assumptions from HW will apply here.  Another assumption is that all of the 
isothermic effects that affect body volume are being controlled:  clothing, body hair, and 
thoracic gas volume (Heyward & Wagner, 2004).  There are many advantages when 
using ADP as a method for assessing body composition.  First, the process is quick, safe, 
non-invasive, painless and comfortable (Wagner & Heyward, 1999).  The system is 
computerized and does not require a lot of technical skill to operate.  Also, the BodPod 
device can be used on many different populations including children, older adults and 
obese individuals (Fields, et al., 2002).  Because of these advantages, ADP using the 
BodPod may be preferable to utilizing HW (Wagner & Heyward, 1999).  However, there 
are disadvantages to using ADP to assess body composition.  First, there are 
assumptions of tissue density that are made when measuring body volume.  Second, 
method used to measure the thoracic gas volume can be difficult for some individuals to 
do, therefore, the volume will need to be estimated causing room for error.  Most 
research on the validity and reliability of the BodPod has been done in the past 10 years 
and has used both DEXA and HW as criterion methods.  Results have been inconsistent 
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across different populations (Fields, et al., 2002).  Ball and Altina (Ball & Altena, 2004) 
point out that comparing the BodPod to HW as a criterion method may not be 
appropriate because they are both assessing the body in two compartments, and 
therefore HW is not technically more accurate than the BodPod. Ball and Altena (2004) 
found a large discrepancy when comparing the BodPod to DEXA as the criterion, with a 
range of individual %BF differences from -6.6 to 9.0%. They also noted that the 
difference in %BF increased as the individual’s BF increased. Concluding that the 
estimations of %BF should be used with caution when classifying individuals as obese.  
However Ballard and colleagues (Ballard, Fafara, & Vukovich, 2004) found with the 
BodPod that mean results of %BF when compared to DEXA as the criterion did not differ 
significantly (P=1.0).  They concluded that the Bod Pod is a valid and reliable method for 
assessing %BF.   
Tetrapolar BIA can be considered both a laboratory and field technique for 
assessing body composition.  Tetrapolar BIA will be discussed further in the following 
section. 
BIA Technology 
Bioelectrical impedance analysis (BIA) is a safe, fast, noninvasive and relatively 
inexpensive method for assessing body composition (Gibson, Heyward, & Mermier, 
2000; Houtkooper, Lohman, Going, & Howell, 1996).  BIA estimates TBW by way of 
electrical current through segments of the body and ultimately predicts BF and FFM.   In 
the following section, BIA will be extensively reviewed.  Discussion of the history, 
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assumptions, and properties of BIA, as well as how BIA assesses body composition and 
the types of BIA devices available for use both healthy individuals and clinical patients 
(Kyle, Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et al., 2004).    
History of BIA 
Beginning in the 1930s, early studies using BIA and body composition focused on 
the “relationship of impedance (of the electrical current) to TBW and to physiological 
variables” (S.B. Heymsfield, et al., 2005), p. 81).  Most research was done using a 
frequency of 50kHz to asses total body water as it related to things such as thyroid 
function and blood flow.  At this low frequency (50kHz), the current only flows through 
extracellular water and does not permeate the cell membrane to assess intracellular 
water.  However, at frequencies greater than 100kHz, the intracellular water can be 
assessed (Foster & Lukaski, 1996; Wagner & Heyward, 1999a).  Multifrequency BIA was 
introduced in the 1970s, when assumptions of BIA were more established, to describe 
the proportion of extracelluar water (ECW) to TBW (Kyle, Bosaeus, De Lorenzo, 
Deurenberg, Elia, Gomez, et al., 2004).  Multifrequency BIA was also used to assess body 
fluid distribution in diseased populations such as those with congestive heart failure, 
and renal disease (S.B. Heymsfield, et al., 2005). Until the mid-1980s, BIA technology 
was primarily used in research and in the medical field.  In the mid 1980s, BIA devices 
became available for commercial use and marketed as a way to measure body 
composition, and thus provide estimates of absolute and/or relative fat mass (S.B. 
Heymsfield, et al., 2005).  By the 1990s, many different BIA devices were on the market 
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for assessing body composition in laboratories, at home, fitness centers, for athletic 
teams, to name a few (Kyle, Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et al., 
2004).  Because of the widespread use of BIA technology, the National Institutes of 
Health (NIH) conducted a one-day summit in 1994 where BIA researchers and industry 
experts discussed safety and standardization of BIA use as well as the validity of the BIA 
devices to estimate body composition (National Institutes of Health, 1996).  The experts 
concluded that BIA is a safe method for assessing body composition in healthy adults.  
However, there are many limitations to using BIA as a method for assessing body 
composition such as body position, individuals with certain diseases, individuals with 
body asymmetry and individuals that are severely obese. 
 
What is Impedance and how is it Measured? 
Many authors and researchers have explained how impedance is measured 
(Dehghan & Merchant, 2008; Heyward & Wagner, 2004; Kyle, Bosaeus, De Lorenzo, 
Deurenberg, Elia, Gomez, et al., 2004).  Terminology between authors is not always 
consistent; however, the theory behind it is the same.  Impedance to the flow of an 
electrical current is measured as an electrical current passes through the body between 
two electrodes.  The voltage drop in electrical current between electrodes is due to the 
impedance of the current flow.  Body composition is estimated based on the principle 
that electrical current flows with less impedance in areas that have high water and 
electrolytes, such as skeletal muscle, compared to less hydrated tissues such as adipose 
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tissue (Esco, et al., 2011a).  Fat-free mass of the theoretical standard reference man 
contains approximately 73% water and electrolytes which makes a good conductor of 
electrical current.  Whereas adipose tissue, which contains very little water, is a poor 
conductor, or it impedes or resists the flow of electrical current (Wagner & Heyward, 
1999).  Thus, the higher the TBW and FFM, the lower the resistance to the electrical 
flow, resulting in a lower impedance value (Wagner & Heyward, 1999). 
 Based on that principle, total body water (TBW) and hydration status are critical to 
obtaining valid body composition results from a BIA device.  Certain activities and 
behaviors performed in close proximity to BIA testing must be controlled such as alcohol 
consumption, consuming products with diuretic properties, food and water 
consumption, and exercise (Dehghan & Merchant, 2008).   
 
Factors Affecting Impedance Measures 
Given the heavy reliance on water content within tissues, hydration status is critical to 
valid and reliable measures of impedance (Dehghan & Merchant, 2008).  Factors that 
can influence hydration status include food and/or water consumption or lack thereof, 
use of diuretics, alcohol consumption and exercise.  The consumption of food and water 
will directly increase the amount of fluid in the body. Use of diuretics will do exactly the 
opposite, increasing the excretion of water from the body through urination.  
Consumption of alcohol, a type of diuretic, will also result in dehydration through an 
increase in urination.  Exercise can affect BIA readings in two ways: 1) loss of fluid from 
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the body due to sweating, 2) increased blood flow to the skeletal muscle and skin which 
increases heat and will decrease the impedance of the current (Dehghan & Merchant, 
2008; Weaver, et al., 2009).  Careful control of all of these variables in a free-living 
environment does not commonly occur when using a hand-held BIA.  But because these 
variables should be controlled in order to obtain an accurate estimate of BF, guidelines 
on pre-test instructions have been created.   
A few published studies have investigated the BIA devices have been and are 
currently used in many fitness facilities, laboratories, clinic and at home.  However, the 
pre-testing guidelines prevent BIA from being a practical way to get valid estimations of 
body composition.  The American College of Sports Medicine (L.A. Kaminsky, 2010) 
recommends the following pre-test guidelines to follow prior to taking BIA 
measurements: 
 No alcohol consumption for previous 48 hours before the test 
 No products with diuretic properties (e.g., caffeine and chocolate) for 24 hours 
before the test 
 No exercise for the 12 hours immediately before the test 
 No eating or drinking for the 4 hours immediately before the test 
 Void bladder within 30 minutes prior to the test 
Because hydration level and pre-testing guidelines are so important in accurate 
impedance measures, many at-home users of segmental devices may not obtain reliable 
or valid results if pre-testing guidelines are not followed.   
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BIA assesses body composition based the impedance of an electrical current that 
passes through a person’s body using Ohm’s law.  A person’s TBW will determine the 
impedance of the currents flow.  As explained by Heyward (2004), there are two 
bioelectrical principles that apply when using BIA.  First, “biological tissues act as 
conductors or insulators, and the flow of current through the body will follow the path 
of least resistance”(Heyward & Wagner, 2004, p. 89).   
Second, impedance is a function of resistance (R) and reactance (Xc) (Kyle, 
Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et al., 2004).  Impedance (Z) is the 
frequency-dependant opposition of a conductor to the flow of an alternating current.  
Resistance (R) is defined as the pure opposition to the current flow through the body.  
Reactance (Xc) is defined as the opposition to current flow cause by capacitance 
(voltage storage) produced by the cell membrane (Heyward & Wagner, 2004)p. 89).  
Therefore, BIA does not necessarily measure FM directly, rather it determines electrical 
impedance, which can be used to estimate TBW.  Based on assumptions concerning the 
aqueous fraction of the FFM, estimates FFM and BF via prediction equations have been 
generated (National Institutes of Health, 1998). 
The biological principles of BIA measurements also follow certain assumptions.  
Estimations of body composition measured by whole-body BIA are based on the 
equation of V= p X (S/R) (Houtkooper, et al., 1996), where V is the conductance volume 
and signifies the volume of TBW or FFM, p is the specific resistivity of the body, S 
represents the length of the conductor or stature, and R is the resistance to the current 
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(Houtkooper, et al., 1996).  The assumptions for this equation are that “the conductor 
has a homogeneous composition, a fixed cross-sectional area and a uniform distribution 
of current density” (Houtkooper, et al., 1996), p. 436).  In summary, this assumes that 
the body is shaped like a perfect cylinder, meaning that ICW and ECW ratios are 
constant providing uniform conductance (Ellis et al., 1999; Gibson, et al., 2000).  This is 
not the case and this assumption is routinely violated.  Because limbs have a smaller 
cross-sectional area than the trunk, “whole body impedance is predominantly 
determined by resistance in the limbs” (Gibson, et al., 2000), p.221).  It is also assumed 
that body tissue is at a constant hydration level, that a 50kHz frequency will penetrate 
all cells equally, and impedance is equal to resistance (Ellis, et al., 1999).  This 
assumption is also not met because of different factors.  First, an individual’s hydration 
level can vary throughout the day.  This could be due to activities that cause 
dehydration such as vigorous exercise or consumption of medications or stimulants that 
have diuretic properties (Dehghan & Merchant, 2008; Kyle, Bosaeus, De Lorenzo, 
Deurenberg, Elia, Manuel Gomez, et al., 2004).  There are also differences in hydration 
level of FFM and fat tissue, with FFM being approximately 73% water and fat tissue 
being relatively anhydrogenous (Kyle, Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et 
al., 2004).  Because these assumptions are not met, regression analysis has been applied 
in previous research to mathematically predict estimates of TBW, FFM and FM from BIA 
impedance measures, anthropometric measures and demographic variables.   
Over the years, many prediction equations developed by multiple researchers.  
These prediction equations were originally based on cross-sectional studies using 
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hydrostatic weighing as a criterion measure (Duz, et al., 2009).  Prediction equations 
most often take into account not only impedance values, but also anthropometric 
values such as height and weight and the individual’s sex and ethnicity to reduce inter-
individual differences in impedance values (Ellis, et al., 1999).  It is difficult to develop a 
BIA prediction equation for a diverse population because, as stated earlier in the Body 
Composition section, previous research has shown that race and age may affect body 
composition and fat distribution (Heyward, 1996).  Most prediction equations have been 
developed and cross-validated for a specific population making results only 
generalizable to like groups (Ellis, et al., 1999; Heyward, 1996).  Another factor that may 
affect prediction equations is amount of body fat.  Some equations overestimate %BF in 
lean populations and underestimate those that are obese (Duz, et al., 2009; Park, Lee, 
Park, Kim, & Kang, 2009; G. Sun et al., 2005; Swartz, Jeremy Evans, King, & Thompson, 
2002).  Lastly, prediction equations are only as accurate as the criterion method used to 
produce the equation (Houtkooper, et al., 1996).  If an equation is based off of a 
criterion measure that itself introduces error when assessing body composition, then 
that prediction equation will have similar errors of estimate.  Because of all of these 
factors, an individual’s estimated %BF could differ by as much as 10% when a specific 
BIA equation is applied (National Institutes of Health, 1998). 
Impedance can be measured by both single-frequency (SF-BIA) and multi-
frequency BIA (MF-BIA) devices.  Most SF-BIA use a frequency of 50kHz that usually 
passes from two different points in the body via surface electrodes to estimate TBW and 
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body composition.  Conversely, MF-BIA estimates body composition using multiple 
frequencies across a large range to assess FFM, TBW, ICW and ECW. 
Single-frequency BIA is technically not measuring TBW, rather it takes a 
weighted sum of ECW and ICW resistance measures (Kyle, Bosaeus, De Lorenzo, 
Deurenberg, Elia, Gomez, et al., 2004).  With a combination of impedance values based 
on the assumption that FFM is 73% water and other data, such as height, weight age 
and sex, body composition can be estimated.  Common SF-BIA devices that are used in 
the field or at home are hand-to-hand and foot-to-foot models, also referred to as 
segmental impedance analyzers.  These devices became available in the 1990s and are 
portable, inexpensive, easy to use and require little to no technician/user experience.  
Hand-held BIA devices have to two handles that contain electrodes where the electrical 
current will be sent out via one electrode and received by the other electrode.  Users of 
this device are instructed to stand upright, firmly grip each to handle with arms 
outstretched at a 90-degree angle to the floor and the current flows from the right to 
left hand.  The technology assumes that the amount of body water in the arms is 
proportional to the whole body (Deurenberg & Deurenberg-Yap, 2002).  There has been 
very little research done on the validity and reliability of the hand-held BIA devices.  
Results have been contradictory, and therefore, inconclusive.  A similar segmental BIA 
device is the foot-to-foot BIA.  In the foot-to-foot device, there are electrodes built in to 
a digital floor scale.  There are usually four electrodes, one for each heel and one for 
each ball of the foot.  Users stand upright, with bare feet positioned properly on the 
electrodes.  The electrical current is sent out via the electrodes at the ball of the foot 
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and received by the electrodes in the heel of the foot (Heyward & Wagner, 2004; Lee, 
2009a).  Body fat percentage is then estimated using manufacturer’s propriety 
equations, which will be discussed in detail later.  Body fat percent is the only result 
displayed for most hand-held and foot-to-foot devices.  Similar to hand-held devices, 
results of validity studies on foot-to-foot devices has been contradictory.   
Unlike SF-BIA, multi-frequency BIA (MF-BIA) devices are able to distinguish 
between ICW and ECW using a combination of low and high frequencies, as low as 1kHz 
up to over 1000kHz (Heymsfield, et al., 2005).  This is important as multifrequency 
impedance measures are able to precisely estimate TBW, ICW and ECW, which was 
limited with single frequency impedance analysis.  MF-BIA has the ability to monitor 
changes in hydration level and fluid shifts in the body.  These devices are helpful in 
monitoring patients with abnormal fluid distribution, such as final stage renal failure 
(Heymsfield, et al., 2005; Heyward & Wagner, 2004).  However, in regards to body 
composition estimates, previous research has shown that single and multifrequency 
impedance measures show similar results.  One example of a MF-BIA device is the 
tetrapolar BIA.  This device is considered a whole body impedance analysis, which uses 
multiple frequencies.  Technically, no measures of BIA can be whole body because the 
head and neck are ignored (Heymsfield, Wang, Visser, Gallagher, & Pierson, 1996).  
While the patient is in a supine position, electrodes are placed on the dorsal surfaces of 
the hand, wrist, foot and ankle on the right side of the body.  The position of the 
electrodes is very important as it can affect the impedance values.  A displacement of a 
mere 1cm can result in a 2% different in impedance (National Institutes of Health, 1998).  
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The proximal electrodes are placed at the metacarpal-phalangeal and metatarsal-
palangeal joints and the distal electrodes are placed at the “piliform prominence of the 
wrist and between the medial and lateral malleoli of the ankle” (National Institutes of 
Health, 1998, pg. 526S).  The electrical current is sent out via the distal electrodes (hand 
and foot) and received by the proximal electrodes (wrist and ankle) (Heyward & 
Wagner, 2004).  Based on measures of TBW, estimations can be made of body %BF, 
FFM, ECW, and ICW.  Previous research has found whole body BIA measures to be 
accurate and reliable for estimating %BF, FFM and TBW.  In 1996 Houtkooper, Lohman, 
Going and Howell reported that when different researchers used the same procedures, 
population, criterion method and same prediction equations, the SEE for FFM was 1.7-
3.0 and 0.23-1.5kg for TBW.  They concluded that whole-body BIA would be accurate for 
assessing body composition for large epidemiological and field studies.  More recently, 
Bosy-Westphal et al. (2008) found a tetrapolar BIA to have good relative and absolute 
agreement when assessing %FM, percent skeletal muscle mass and total body bone-free 
lean mass when compared to both DEXA and magnetic resonance imaging (MRI).  They 
concluded that terapolar BIA would be a valid tool for assessing body composition in 
individuals.  Furthermore, Fornetti, Pivarnik, Foley and Fiechtner (1999) found tetrapolar 
BIA to be a reliable and valid tool for assessing body composition.  When compared to 
DEXA, tetrapolar BIA had approximately a 1.8% prediction error in estimating %BF.  
 
 
 
38 
 
 
Validity of the Hand-held BIA 
Very few research publications are available on the validity of the hand-held BIA 
device in estimating %BF.  Moreover, even less has been published on the validity of the 
Omron HBF-306C which is a recently released hand-held device by Omron Healthcare 
that will be used in this study.  There have been conflicting results on the validity 
because the populations in the published studies have differed in age, race and sex, all 
which affect the proprietary prediction equation used in each of the hand-held devices.  
For discussion purposes, previous validation studies will be addressed in order by type 
of hand-held device examined.  That will be followed by critical gaps in the literature 
based on the nine validation studies that have been published and discussed in this 
section.   
In 2000, Gibson, Heyward and Mermier (Gibson, et al., 2000) published a 
validation study of one of the earlier model of the Omron hand-held body fat analyzers, 
the Omron HBF-300 (see Figure 3).  With a subject population of 25 men (age 19-55 
years, mean BF 18.7±8.1%) and 23 women (age 18-48 years, mean BF 21.8±7.2%), both 
White and non-White, they compared the %BF from the BIA device with HW as the 
criterion method.  Prior to all assessments, subjects were instructed to fast from food 
and drink for four hours, emptying bladder and bowels within 30 minutes of testing, and 
avoiding strenuous exercise for at least 12 hours prior to testing.  Results indicated that 
approximately 70% of men and 66.6% of women tested received an accurate estimate 
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of %BF from the hand-held BIA.  Accuracy was defined by an estimate within ± 3.5 %BF 
when compared to the HW as the criterion method.   
Duz, Kocak and Korkusuz (2009) investigated the validity of the Omron BF-300 
Body Fat Monitor in estimating %BF when compared to DEXA as the reference method.  
It is not clearly stated if the subjects followed pre-testing guidelines to control for 
hydration status.  Among 18-26 year old males (n=104) and females (n=104) college 
students, they found that BIA significantly underestimated %BF in females and males 
(19.2±1.0% for females and 13.7±4.9% for males), however, more so in females when 
compared to DEXA (28.4±1.3% for females and 18.5±6.2% for males).  In addition, they 
determined that the bias in BIA increased as body fat increased in participants.  They 
concluded that different prediction equations should be developed or current prediction 
equations be revised to accurately represent a diverse population.   
The most recent published study investigating the accuracy of a hand-held BIA 
device was conducted by Esco and colleagues and published in 2011.  A total of 40 
female collegiate athletes, between the ages of 18 and 27 years, participated in the 
study.  All participated in either soccer (n=19), tennis (n=10) or basketball (n=11).  Prior 
to the lab visit, participants were instructed to fast two hours prior to testing and to 
avoid alcohol consumption for 24 hours prior to testing.  The Omron HBF-300 was used 
and compared to DEXA as the criterion method for estimating %BF and FFM.  It was 
determined that %BF was significantly underestimated and FFM was significantly higher 
from the hand-held BIA as compared to the DEXA.  These results are parallel to most 
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previous validation studies of the hand-held BIA that the devices lack accuracy when 
estimating %BF when compared to a criterion method. 
Varady, Santosa and Jones, in 2007, conducted a validation study on the Omron 
BF-302 (see Figure 4) hand-held BIA device.  Percent body fat differences were 
compared between the hand-held BIA and Magnetic Resonance Imaging (MRI) as the 
criterion method.  The participant pool consisted of overweight, Caucasian females 
(n=31) aged 35-60 years who were free of any diagnosis of any disease leading to fluid 
imbalance and not taking any medication affecting water and salt balance.  Participants 
were given several pre-testing guidelines to control for hydration status prior to BIA 
measurements: fasting for three hours, avoid strenuous exercise for 12 hours, and void 
bladder within 30 minutes of assessments.  Results indicated that the hand-held BIA 
significantly underestimated mean %BF and FM when compared to MRI.  In addition, 
hand-held BIA overestimated %FFM and FFM when compared to MRI.  The authors 
concluded that the validity of the device is in question. 
Erceg and colleagues (2010) published a report on the accuracy of the 
Stayhealthy BC1 hand-held BIA device (see Figure 5) when compared to DEXA as a 
criterion method.  This device is different from all of the Omron models in that it gives 
not only measures of BF but also LM and hydration index.  Additionally, the data can be 
uploaded from the device to a personal computer.  Adults (117 men and 128 women) 
ages 18-80 participated in the study.  Participants were divided into the following age 
ranges:  18-35, 36-50, 51-60, 61-70 and 71-80.  The study was one of the first to analyze 
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accuracy of a hand-held BIA across a large age span.  Participants had BMI ranging from 
normal to obese and the sample was ethnically diverse.  There was no mention of 
participants following pre-testing guidelines prior to BIA measures.  Results were 
contrary to many previous reports on validity of hand-held BIA devices.  There were no 
significant differences across age groups for each sex when comparing %BF from the 
hand-held BIA and DEXA measurements, indicating that the Stayhealthy hand-held BIA 
device is a valid tool for estimating percent %BF in a diverse population of healthy 
adults.  
Deurenberg and Deurenberg-Yap (2002) conducted a validation of the Omron 
BF-306 (see Figure 6) hand-held body fat analyzer using a four-compartment model as 
the reference method in Chinese, Malay and Indian subjects.  Participants’ age ranged 
from 18 to70 and they were also purposefully selected to include a large range of BMI 
values over the age span.  Before assessments, subjects were instructed to abstain from 
food and drink for at least 6 hours and were instructed to void bladder just prior.  
Significant differences between %BF from BIA and the reference method were found in 
Malay and Indian men, who were higher in mean age and also had the highest mean 
%BF based from the reference method among sex and ethnicities.  They also found that 
Indian subjects, who had a larger arm span relative to their height (women 1.0±0.0 and 
men 1.0±0.0) compared to the other ethnic groups, had higher impedance values.  The 
authors concluded that factors of ethnicity and body type play a role in observed bias 
when using prediction equations that were validated on mostly white, European 
subjects.   
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Lintsi, Kaarma and Kull (2004) included multiple models of hand-held BIA 
devices: two Omron BF-300 (series 8), one Omron BF-300 (series 9), and one Omron BF-
306 in a study aimed at examining differences in %BF among the three hand-held 
devices and DEXA as the criterion method in 17-18 year old males in the military.  The 
subjects were given no pre-testing guidelines to follow, meaning that researchers were 
not controlling for hydration status.  All four hand-held BIA devices underestimated %BF 
when compared to DEXA, and three of them were statistically significant.  The two 
Omron BF 300 (series 8) devices provided means for %BF of the group and difference 
estimates that were not significantly different.  The Omron BF-300 (series 9) had the 
largest difference in %BF compared to DEXA and the Omron BF-306 had the closest 
estimations of %BF compared to DEXA.  Although three of the devices were provided 
%BF means that were statistically different from DEXA, the estimations of %BF were not 
necessarily clinically significant.   
Weaver, Hill, Andreacci and Dixon reported results in 2009 on the validity of the 
Omron HBF-306C in estimating %BF as compared to air displacement plethysmography 
(ADP) as the reference method (Weaver, et al., 2009).  Not only was the study a cross-
sectional study comparing %BF in a single laboratory visit with subjects complying to 
pre-testing guidelines, an exercise component was added.  Forty-one, healthy young 
adult men and women, ages 18-32y, volunteered for the study.  Subjects came in for the 
first laboratory visit for validation purposes, where they were given pre-testing 
guidelines to control hydration status, such as fasting, avoiding exercise, avoiding 
alcohol consumption and no diuretic mediation within certain timeframes of testing.  
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Percent body fat was analyzed with the Omron HBF-306C device as well as the BodPod 
body composition system.  During the second visit, %BF was assessed before and after a 
30 minute exercise bout to determine the impact of changes in body temperature and 
hydration on BIA measures.  The validation measures resulted in an underestimation of 
%BF by the hand-held BIA when compared to ADP, but the difference was only 
statistically significant in women.  Results also indicated that the hand-held BIA device 
overestimated %BF in subjects with lower %BF and underestimated those with higher 
%BF.  This is consistent with previous literature that suggests BIA underestimates %BF as 
%BF increases in populations (Deurenberg & Deurenberg, 2002; Duz et al., 2009, Varady, 
et al.,2007 ).  Even more, 50% of women and 40% of men had %BF estimations by hand-
held BIA that fell outside of acceptable range (±3.5%).  When hand-held BIA 
measurements were taken pre- and post-exercise, there was a significant drop in %BF as 
a group, but differences were not significant when analyzed separately by sex.  Author’s 
concluded that estimations of %BF by hand-held BIA are not as accurate as desired on a 
group and individual basis.  Most of the differences that were found statistically 
significant are not, however, clinically significant.  The only clinically significant 
difference in %BF from the hand-held BIA compared to ADP was found when validating 
the device in women.   
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Figure 3. Omron BF 300 
 
 
 
 
 
 
 
 
 
Figure 4. Omron BF 302 
 
Figure 5. Stayhealthy BC1 
 
Figure 6. Omron HBF-306C 
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Gaps in the Literature 
 Because hand-held BIA devices are relatively new, commercially-available 
products, there is very little research is available on their validity and reliability.  One 
major gap in the literature is evaluating the accuracy and reliability of, specifically, the 
Omron HBF-306C device.  It is one of three hand-held BIA devices currently on the 
market.  However, there has been some research done examining accuracy of previous 
versions of the HBF-306C and other similar devices.  Another major gap in the literature 
is the accuracy and reliability of hand-held devices across a large age span.  Most of the 
previous research has been completed using young adults, rarely including subjects over 
the age of 60.  This is important because of the changes in FM and FFM as adults age.  
Additionally, more research needs to be done on the accuracy and reliability across sex.  
The amount of BF and BF distribution is most often different between men and women, 
and it is important to determine if those differences alter the validity of the device. It is, 
therefore, critical to validate this device across the two variables of age and sex.  Lastly, 
although the concept of euhydration is extremely important in the assessment of body 
composition with BIA devices, only one of the previous validation studies on hand-held 
BIA devices has controlled for hydration using all of the ACSM pre-testing guidelines.  
This could be a major limitation to all of the validation studies previously conducted on 
hand-held BIA devices.  It is also important to compare the results of BF measures from 
the hand-held BIA device to the criterion measures in both a controlled setting when 
individuals are euhydrated and in a free-living environment when the pre-testing 
guidelines are not necessarily followed.  This comparison is important as it will 
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determine whether the pre-testing guidelines, in fact, do need to be controlled for when 
estimating BF with hand-held BIA devices. 
 
Summary 
 Because of the increase in overweight and obesity, and the associated health 
risks, many individuals are self-monitoring body composition.  There are many methods 
available to monitor body composition, more specifically body fat; however, not all are 
readily-available or cost-effective for many individuals to use.  Bioelectrical impedance 
analysis is one method that has been used to assess body composition since the 1930’s, 
but as early as the 1990’s this technology has been commercially-marketed as an easy-
to-use, inexpensive, portable hand-held device.  These hand-held devices are used to 
monitor %BF at home, fitness centers and clinics.  Based on BF results from these 
devices, individuals make health-related decisions about diet and exercise programs.  
Therefore, it is critical that these devices are valid in estimating body fat.  Because hand-
held devices are relatively new, there is little research done on the validity or reliability.  
Previous research has been contradictory, and therefore inconclusive.  More research 
needs to be focused on the validity of hand-held devices in controlled and free-living 
settings to see if hydration status does, in fact, play a critical role in accurate BF 
measures.  Moreover, research on validity of hand-held devices needs to be expanded 
across both sexes and across young and old adults.   
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Chapter 3: Methods 
 
 
 Many individuals self-monitor their body composition based on physician’s 
fitness and health recommendations or their own desire to favorably alter their body 
composition , often using portable, inexpensive body composition assessment tools.  
Individuals use the body composition information obtained from these devices to help 
them make health-related decisions and to track progress of an exercise or 
recommended diet program, or other health interventions.  Therefore, it is important 
that these devices are valid in assessing body composition. 
 The purpose of this study was to evaluate the validity and reliability of a 
commercially-available hand-held bioelectrical impedance analysis (BIA) device as a 
measure of body composition for adults in a controlled laboratory condition and during 
a free-living condition.  This section will include descriptive information of the 
participants, a description of instruments used, details of the study protocol and the 
statistical analysis. 
 
Study Design 
This study used a cross-sectional design with two data collection periods to 
investigate the validity and reliability of a hand-held bioelectrical impedance analyzer.  
Time point one, which addressed specific aim 1, was a controlled laboratory condition 
when body composition measures from the hand-held BIA was compared to two 
criterion measures of body composition, DEXA and tetrapolar BIA, across age and sex 
when pre-testing guidelines had been followed. 
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Independent Variable: Body composition assessment device 
Dependent Variables: %BF 
 The second time point, which addressed specific aim 2, was during the free-living 
condition, occurring within 72 hours of the laboratory visit.  Participants used a hand-
held BIA at four pre-set times to estimate BF, when pre-testing guidelines may or may 
not have been followed. 
    
Independent Variable:  Time of measure 
Dependent Variables:  %BF 
 
Other Variables of Interest 
 Variables for this study included body mass index, waist circumference, hip 
circumference, and arm span. 
 
 
Participants 
 
Participants were recruited via flyers posted on the University of Wisconsin-
Milwaukee (UWM) campus, at local fitness centers, local businesses and senior living 
facilities in the Milwaukee metro area (Appendix A); presentations in large classes 
including both health and non-health majors; word of mouth; website information; and 
database including individuals that have consented to receiving phone calls for 
recruitment of studies held in the UWM Physical Activity & Health Research Lab.   
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The participants in this study included adults between the ages of 18 and 39 
years and between the ages of 55 and 75 years.   A screening form was administered 
over the phone or in person to determine eligibility for participation in the study 
(Appendix B).  Inclusion criteria included participants who are White and English-
speaking.  Because of the many differences in body composition between different 
races, this study focused on White individuals first, with aspirations of continuing with 
other races in the future.    Also, participants had to be English-speaking as all study-
related documents were written in English, and the laboratory staff were only fluent in 
English. Purposeful sampling was used to recruit an equal number of males and females 
in each age category, as well as selecting a range of BMI among participants in each age 
category.    
Exclusion criteria included individuals with a condition or taking medication that 
alters hydration status of the body including diuretic medication or calcium channel 
blocker; current diagnosis of a metabolic or kidney disease, pulmonary disease, or 
cirrhosis.  Participants were also excluded if they had any cardiovascular condition or a 
pacemaker.  Because BIA uses a small electrical current to measure body composition, 
the BIA devices should not be used on individuals that have a pacemaker in the rare 
instance that it may alter the electrical rhythm of that pacemaker.  Any female that was 
pregnant or trying to become pregnant was excluded because of the radiation from the 
DEXA scan.  Any female age 55 years and older that was still in the stages of menopause 
because previous research has demonstrated that BIA may not be a valid device for this 
population (Dehghan & Merchant, 2008).  Lastly, any individual with a limb amputation 
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because previous research has shown that the assessment of body composition with BIA 
may not be accurate in those that have body asymmetry (National Institutes of Health, 
1996).    
Participants were also asked to self-report their height and weight in order for 
purposeful sampling of participants that span a wide range of body mass indexes.  
Because previous research has shown hand-held BIA to overestimate %BF in leaner 
individuals and underestimate %BF in overweight individuals, it was important to 
include participants of all sizes in the study (Deurenberg & Deurenberg-Yap, 2002a).    
 
Protection of Human Participants 
All study procedures were approved by the University of Wisconsin-Milwaukee 
Institutional Review Board and the Radiation Safety Program in the Department of 
University Safety and Assurances at the University of Wisconsin-Milwaukee, assuring 
protection of study participants.  All participants were required to sign an informed 
consent document prior to participating (Appendix C). 
 
 
Instrumentation 
 
Body composition measures were estimated used three different devices.  Both 
the hand-held and tetrapolar bioelectrical impedance analyzers estimate total body 
water and FFM, and calculate body fat using predictive regression formulas.  Dual-
energy x-ray absprtiometry provides information on body fat, as well as bone mineral 
content (BMC) and mineral-free lean tissue.   
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Hand-Held Bioelectrical Impedance Analysis 
Commercially-available hand-held BIA devices are used to estimate %BF.  While 
the individual is standing, gripping the handles of the device with arms straight out from 
the body, a 50kHz electrical current travels from one hand to the other, while the device 
measures the drop in voltage, or impedance to the current’s flow.   In the case of the 
Omron HBF-306C, the Impedance, along with height, mass, age and sex, are entered 
into a proprietary regression equation to estimate %BF.  The current study used the 
battery-operated Omron Fat Loss Monitor (HBF-306C, Omron Healthcare, Bannockburn, 
Ill).   More details on the procedure of using this device are presented in Study Protocol 
section. 
There are numerous advantages to a using a hand-held BIA including the 
following: 
 It is easy to use and little technical skill required.   
 This method is non-invasive.  The device uses a 50kHz electrical current 
that is not felt by the participant.  The frequency is very low and 
therefore is safe for most individuals to use.   
 The device is lightweight, weighing approximately 8 oz.  The device is 
small and portable with dimensions of 8in (length), 5in (height) and 2in 
(width).  Because the device is lightweight and portable, it can be used in 
many different settings such as at home, in fitness center or clinics.   
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 The device is cost effective and can be owned and utilized by individuals, 
clinics, and health/fitness facilities.   
Although the device is easy to operate, there are strict pre-testing guidelines 
that the user must follow to elicit accurate results.  These guidelines may make this 
device less practical than marketed.  Additionally, users of the device may not even be 
aware of these pre-testing guidelines, resulting in invalid estimations of %BF.   
There is very little research conducted on the validity and/or reliability of the 
Omron HBF-306C, and those results have been contradictory.  Because of the 
contradictory results, the current study will be testing the validity of this device across 
age and sex.  This may be due to the different subject populations used in the studies 
and the pre-testing guidelines that were used to control for hydration status 
(Deurenberg & Deurenberg-Yap, 2002b; Lintsi, Kaarma, & Kull, 2004a; Weaver, et al., 
2009). 
 
Tetrapolar Bioelectrical Impedance Analysis 
 Absolute and relative total body fat mass was assessed using a tetrapolar 
bioelectrical impedance analysis (BIA) device.  A battery-operated, multifrequency 
bioelectrical impedance analyzer, The QuadScan 4000 (Bodystat®, Douglas, Isle of Man), 
will be used in the current study.  Using this device, impedance can be measured at 
frequencies of 5, 50, 100 and 200kHz, however, for the purpose of assessing body 
composition, only 50kHz will be used.    Self-adhesive, disposable electrodes are placed 
on the right hand and foot.  Two sets of source and sensor electrical leads are required, 
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one set for the foot electrodes and one set for the hand electrodes.  Distal electrodes 
(attached to the red lead) send out the electrical current and proximal electrodes 
(attached to the black lead) receive the electrical current.  More details on the 
procedure will be presented in the “Procedure” section. 
Previous research has found the QuadScan 4000 device to have contradictory 
results when estimating %BF.  Fornetti, Pivarnik, Foley and Fiechtner (Fornetti, Pivarnik, 
Foley, & Fiechtner, 1999) found tetrapolar BIA to be a reliable and valid tool for 
assessing %BF.  When compared to DEXA, tetrapolar BIA had approximately a 1.8% 
prediction error in estimating %BF.  Sun and colleagues (G. Sun, et al., 2005) found that 
the QuadScan 4000 significantly underestimated overall %BF in both men and women 
(p<0.001) when compared to DEXA.  Although the results were statistically significant, 
they may not be considered clinically significant.  When the authors examined the group 
more closely, they found that the QuadScan 4000 overestimated %BF in lean individuals 
(%BF <20% for males and <25% females) and underestimated %BF in overweight or 
obese individuals (%BF >30% for males and >33% for females).  Sun and colleagues 
concluded that the QuadScan 4000 is a valid tool for estimating %BF in individuals within 
a normal body fat range.  Overall, tetrapolar BIA devices, including the QuadScan 4000, 
have been found to be valid devices for estimating %BF in most populations.  Therefore, 
the QuadScan 4000 was used as another comparison method in this study.   
Advantages to using the tetrapolar BIA method for assessing body composition 
are that the procedure is quick and non-invasive.  The device also requires little training 
to operate and is relatively inexpensive as compared to other laboratory-based 
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methods.  Although the use of the device requires little training to operate, the 
placement of the electrodes on the hand and foot is very important.  A displacement of 
a mere 1cm can result in a 2% different in impedance (National Institutes of Health, 
1998). Similar to the hand-held BIA device, there are also strict pre-testing guidelines 
that the participant must follow in order to be normally hydrated.  If these guidelines 
are not met, the impedance measures of the tetrapolar BIA will not be accurate.   
The QuadScan 4000 self-calibrates prior to each measurement.  Additionally, 
there is an option for the technician to manually calibrate the device, which was done 
weekly.  To manually calibrate prior to each measurement, both sets of leads are 
connected to a manufacturer-provided calibrator.  There were no abnormal results 
when manually calibrating the device.   
 
Dual-energy X-ray Absoptiometry 
Dual-energy x-ray absorptiometry is a tool originally designed to estimate bone 
mineral density, but has more recently emerged as a tool for estimating FM as well as 
mineral-free lean mass (T. G. Lohman, 2005).   Individuals lay supine and are positioned 
in the center of the DEXA table.  Mineral-free lean mass, FM and BMD are estimated 
based on the tissue attenuation of two different x-ray energies (Pietrobelli, et al., 1996).  
The x-ray beams pass from the posterior to anterior of the body to a detector that is 
above the participant (Duz, et al., 2009).  Based on the attenuation, and known densities 
of FM and FFM, the three compartments can be distinguished.  The device used for this 
study was the Lunar Prodigy Advance software version (GE, Madison, WI). 
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There are many advantages to using DEXA to assess body composition.  First, 
because this is a three compartment model of body composition, taking into account 
BMC, there are fewer assumptions that must be met and results are more consistently 
valid.  Another advantage is that little participant compliance needed.  Participants are 
not required to following any pre-testing guidelines such as fasting or avoiding 
strenuous exercise that are required for BIA assessments.  Lastly, the DEXA is non-
invasive and participants will not feel anything during the scan.  
There are disadvantages of using DEXA to assess body composition.  DEXA 
assesses body composition using an x-ray method, and therefore participants will be 
exposed to radiation.  The device being used for this study emits approximately 0.00004 
mRem of radiation which is similar to a cross-country flight and is fractions less than the 
amount of radiation from a typical x-ray, such as a chest x-ray.   Therefore, it is 
considered safe for almost all populations (T. G. Lohman, 2005).   Because of the size of 
the Lunar Prodigy table, there may be restrictions based on participant’s size.  The 
weight limit for the device is 159.1 kg.  The total table size is 262cm long and 89cm wide, 
however, the area for scan is much smaller.   Individuals that are taller than 193cm and 
wider than 60cm, will not receive accurate assessments as their entire body will not fit 
within the scan area.   DEXA is an expensive and non-portable device that, depending on 
state laws, may require a certified or registered technician.  Because of these reasons, 
DEXA may not be available for use by all individuals.   
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DEXA has, in recent years, been considered a gold standard method for assessing 
body composition because previous research has shown it to be both valid and reliable.  
Because of this, it will be used as a criterion measure in this study.  Pritchard, Nowson, 
Strauss, Carlson, Kaymakci and Wark (1992) found that DEXA had greater precision 
when measuring fat mass when compared to HW, with a coefficient of variation of 1.8% 
for percent body fat and 2.1% for fat mass.  Lohman, Tallroth, Kettunen and Marttinen 
(M. Lohman, Tallroth, K., Kettunen, J. A., Marttinen, M. T., 2009) conducted reliability a 
study using the Lunar Prodigy densitometer.  They found total body DEXA measures to 
be repeatable for lean mass (LM) (r=0.99), FM (r=1.00) and BMD (r=1.00).   
The Lunar Prodigy was calibrated daily prior to all measures using the 
manufacturer provided calibration block and using the manufacturer’s instructions.  The 
device was also calibrated weekly using the calibration phantom and using the 
manufacturer’s instructions.  There were no abnormal results when calibrating the 
DEXA.  
 
 
Procedure 
 
Laboratory and Experimental Information 
All testing took place in the Physical Activity and Health Research Lab at UWM 
(Enderis 434).  The cross-sectional research design included data collection during one 
laboratory visit that lasted approximately one hour and 15 minutes, and a second visit 
that lasted approximately 15 minutes.  Laboratory visits were separated by a 24-hour 
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free-living day, within 72 hours of the first laboratory visit.  The free-living day was a 
repeated-measures reliability research design.   
 
 
Information Provided to Participants 
When individuals inquired about participation in the study, a screening form 
(Appendix B) was administered over the phone or in person to determine eligibility. 
Participants were informed that they were eligible if they met all inclusion criteria and 
were found to have no exclusion criteria.  Individuals were informed of the details and 
time requirement of the study protocol, after which, it was of the individual’s discretion 
if he/she would like to enroll in the study.  If individuals wanted to enroll as participants, 
they determined, along with the researcher, the scheduled dates and times to come in 
for the laboratory visits.  Because all participants completed the same protocol, there 
was no randomization into treatment groups.  The participants were given directions to 
the Physical Activity & Health Research Laboratory as well as instructions on parking.   
Seventy-two hours prior to attending the first laboratory visit, participants were 
asked via phone and/or email to strictly adhere to pre-visit instructions: No alcohol 
consumption 48 hours before visit 1; no products with diuretic properties (caffeine, 
chocolate) for 24 hours before visit 1; no exercise 12 hours immediately before visit 1; 
no eating or drinking 4 hours immediately before visit 1; and void bladder within 30 
minutes prior to the BF assessment.    
Participants were asked to abide by these pre-testing guidelines to ensure that 
each individual was euhydrated.  This was important for the BIA measurements that was 
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completed during the first laboratory visit.  If these guidelines could not be met, the 
participant could reschedule the laboratory visit date, otherwise, they were withdrawn 
from the study.  One participant was withdrawn from the study due to not abiding by 
the pre-testing guidelines.   
 
Study Protocol 
Laboratory Visit 1 
Participants reported to the Physical Activity and Health Research lab at his/her 
individually scheduled time.  During the first laboratory visit, participants were given a 
full description of the study and informed consent was obtained (Appendix C).  Due to 
the x-ray exposure during the DEXA procedure, all female participants of child-bearing 
age were required to take a pregnancy test.  If the pregnancy result was positive, 
participants were not be able to complete portions of the study, and were considered 
ineligible.  No participants had a positive pregnancy result.  All participants then 
completed a general health history and demographic questionnaire (Appendix D) to 
determine any current health risks or conditions that would limit normal daily living 
activities and confirm eligibility.  Following the health history questionnaire, measures 
of resting heart rate and blood pressure were taken to evaluate cardiovascular risk 
factors.  If participants were hypertensive, they were instructed to speak with their 
physician and were withdrawn from the study.  Blood pressure was measured following 
protocol as outlined in The Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (Chobanian et 
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al., 2003) with a mercury sphygmomanometer (972 Series; American Diagnostic Corp, 
Hauppauge, NY).   Resting heart rate and blood pressure were measured two times with 
the right arm and averaged for reporting.  Anthropometric measures of body mass, 
standing height, and waist and hip circumference measures were obtained using 
guidelines outlined by the American College of Sports Medicine (ACSM) (Ehrman, 2010; 
Leonard A. Kaminsky, 2010).  Body mass (kg) was measured to the nearest 0.01kg using 
a balance-beam scale (339; Detecto, Web City, MO) while participants wore light 
clothing, were instructed to remove items from pockets and jewelry, if possible, and 
wear no shoes.  While shoes were still removed, standing height (cm) was measured to 
the nearest 0.1cm using a wall-mounted stadiometer (3PHTROD; Detecto, WebCity, 
MO).  Participants were instructed to stand upright with heels together, looking straight 
ahead.  Next, they were instructed to take a deep breath and hold it while the horizontal 
bar of the stadiometer is lowered to the head, compressing the hair.  Body mass index 
(BMI) was then calculated using the measured height and body mass measures (kg/m²).  
Next, waist and hip circumference (cm) was measured to the nearest 0.5cm using a 
Gulick tension-fitted tape measure (M-22C; Creative Health Products, Ann Arbor, MI).  
Waist circumference was measured with the participant standing upright with arms at 
the side and feet together.  The tape measure was placed horizontally at the narrowest 
part of the torso, above the umbilicus and below the xiphoid process (Leonard A. 
Kaminsky, 2010).  Hip circumference was measured with the participant standing and 
feet together.  The tape measure was placed horizontally and measurement was taken 
at the largest circumference of the buttocks (Leonard A. Kaminsky, 2010).  Two 
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measurements were taken at each site.  If measures were not within 0.5cm, additional 
measures were taken until two measures were within 0.5cm to be averaged for analysis. 
Lastly, arm span was measured to the nearest 0.1cm using procedures specified in the 
Arlie Conference Proceedings (Lohman, Roche, & Martorell, 1991).  Arm span was 
measured with a wall-mounted tape measure while participants’ back was up against 
the wall, feet are together, arms abducted laterally forming a 90 degree angle with the 
body, and palms facing forward.  The measure was made from the end of the middle (or 
longest) finger on the right hand, directly across the back of the body to the end of the 
middle (or longest) finger on the left hand, excluding fingernail.  Arm span measures 
were used to determine if arm length affects impedance values assessed with the two 
BIA devices. 
Participants then had their BF measured by three separate devices always in the 
same order: dual-energy x-ray absorptiometry (DEXA; Lunar Prodigy, GE, Madison, WI), 
tetrapolar BIA  (Bodystat® Quad Scan 4000; Douglas, Isle of Man ), and an Omron HBF-
306C (Omron Healthcare, Bannockburn, IL ) hand-held device.  The tetrapolar BIA and 
DEXA were calibrated prior to each assessment.  There was no calibration process for 
the Omron HBF-306C device.   
Prior to the DEXA assessment, participants were asked to remove any metal 
objects on their body such as jewelry, buttons and zippers.  If participants did not have 
alternate, metal-free clothing, a t-shirt and shorts were provided.  Additionally, 
participants were asked to remove socks and shoes. The participant’s, height, body 
mass, age, sex and race were entered into the DEXA computer software program.  The 
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participant remained supine on the DEXA table, with his/her body positioned within the 
scan area that is denoted by a white rectangle on the table.  Additionally, the body was 
positioned so that the white center line on the DEXA table was directly in line with the 
center of the participant’s body.  The participant was instructed to lie as still as possible 
without talking, but breathe normally during the scan.  The scan took between six and 
12 minutes, depending on the height and scan mode selected for measurement of the 
participant.   
Immediately following the DEXA measurement, participants remained supine 
and completed the second measure: tetrapolar BIA.  The technician positioned the 
participant’s body so that all of the four limbs were separated and not touching any of 
the other limbs.  Once positioned, the participants’ dorsal surfaces of the hand, wrist, 
foot and ankle on the right side of the body was cleaned with alcohol pads. Electrodes 
were placed on the four cleaned areas.   The proximal electrodes were placed at the 
metacarpal-phalangeal and metatarsal-phalangeal joints and the distal electrodes were 
placed at the piliform prominence of the wrist and between the medial and lateral 
malleoli of the ankle (Stamatakis, Davis, Stathi, & Hamer, 2011).  Participants’ height, 
body mass, sex, age, waist and hip circumferences were entered into the QuadScan 
4000 device and body composition was assessed using the tetrapolar BIA.  Once 
electrodes were placed and information was entered into the device, the technician 
started the tetrapolar BIA measure which lasted approximately one minute.   
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After completion of the supine BF measures, participants were asked to stand for 
3 minutes.  Participants remained in the same clothing with shoes still removed.  Height, 
body mass, age and sex were entered into the hand-held device.  All measures with the 
hand-held BIA device were done on the “normal” setting as opposed to the “athlete” 
setting.  After three minutes of standing, two consecutive BF measurements were 
completed with the hand-held Omron HBF-306C.  Participants were asked to grip the 
handles of the device firmly with thumbs pointing up and extend arms out straight in 
front of his/her body, parallel to the floor.  After the first measure was completed, the 
participant remained standing with arms relaxed at his/her side for 60 seconds.  Then, a 
second measure was taken with the hand-held device.  The two measures were 
averaged and recorded for analysis.   
Once BF measures were completed, participants received detailed verbal and 
written instructions (Appendix E) on how to use the hand-held BIA for the free-living 
day.  Participants were advised of specific times of the day to take and record BF 
measures with the hand-held BIA device. Participants were asked to complete an event 
log (Appendix F) during the free-living day which included times when the following 
actions occurred:  waking time, eating meals or snacks, ingesting beverages or 
medications, time of any food or beverage comsumption,  time of structured exercise (if 
they exercise during that day), time of any leisure activites throughout the day, time of 
going to bed, and hand-held BIA body fat measures at the four pre-selected times.   
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Free-living condition  
Participants brought home the Omron HBF-306C hand-held BIA device. The 24-
hour free-living day occurred within 72 hours of the first laboratory visit for all 
participants.  Participants were instructed to assess BF via the Omron HBF-306C device 
at specific times of the free-living day: 1) immediately upon waking and voiding bladder, 
2) immediately after eating lunch, 3) right before going to bed, and 4) immediately after 
exercising (if exercise was done during the day). These times were specifically selected 
because some are the most popular times of the day to take body weight measures 
(Klos, et al., unpublished data), and are thus times that an individual will likely self-
monitor their BF level.  However, some of the measures were specifically taken after 
activities that have been shown to affect hydration status, and therefore, were expected 
to affect BIA output.   
Participants also recorded specific events during the free-living day in the event 
log.  Events that were documented include the following: waking time, eating meals or 
snacks, ingesting beverages or medications, time of any food or beverage comsumption,  
time of structured exercise (if they exercise during that day), time of any leisure activites 
throughout the day, time of going to bed, and hand-held BIA body fat measures at the 
four pre-selected times.   
Laboratory Visit 2 
Participants returned the hand-held BIA device, daily log and accelerometer to 
the laboratory within four weeks of the free-living day where they were provided with 
results from their DEXA and tetrapolar BIA measurements. 
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Statistical Analysis 
All statistical analysis was conducted using SPSS 18 for Windows (SPSS, Inc. 
Chicago, Il). An alpha level of greater than 0.05 was used for the statistical significance 
level.  Demographic variables including height, body mass, BMI, waist and hip 
circumferences, waist-to-hip ratio, and arm span were assessed and are displayed as 
means, standard deviations, minimum values and maximum values. 
To address the primary aim of the study, a mixed between by within design 
comparing sexes and age groups (between groups variables) across hand-held BIA, 
tetrapolar BIA and DEXA measurements (within groups variable) was performed to 
determine whether differences among devices exist.  Post-hoc comparisons were 
performed to determine which devices are different in assessing BF among the hand-
held BIA, the tetrapolar BIA and the DEXA.  Additionally, Bland Altman Plots were 
created to visually depict the agreement between %BF estimates form the hand-held 
BIA as compared to the DEXA for individual participants.  Medical researchers often 
need to compare two methods of measurement to determine whether these two 
methods can be used interchangeably.  The 95% limits of agreement are for visual 
judgment of how well two methods of measurement agree. The smaller the range 
between these two limits the better the agreement is.  That definition depends on the 
clinical acceptance standard for the method, which in this case is ±3.5%.  Waist 
circumference, arm span and BMI were examined as potential covariates in the validity 
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of the hand-held BIA measures.  These variables were added if determined to fit 
covariate assumptions   
To address the second aim of the study, repeated measures analysis of variance 
was performed to determine if there are differences in the hand-held BF measures over 
the duration of the free-living day and also with the controlled laboratory hand-held BF 
measures.  Post-hoc comparisons were performed to determine what specific 
measurement times and situations cause significant differences in BF measures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
 
Chapter 4: Results 
 
Introduction 
Because of the increase in overweight and obesity, and the associated health 
risks, many individuals are self-monitoring body fat with affordable and easy-to-use 
devices.  There are many different methods available to self-monitor body fat (BF).  One 
such device, the hand-held BIA device, is an affordable and easy-to-use method that is 
increasing in popularity.  The purpose of this study is to evaluate the validity of a 
commercially-available hand-held bioelectrical impedance analysis (BIA) device as a 
measure of body fat for adults in a controlled laboratory condition and evaluate the 
reliability of this device during a free-living condition.  In order to address this purpose, 
this study focused on two specific aims. 
Specific Aim 1: To compare body fat measures from the hand-held BIA to two 
additional methods used to estimate body fat, DEXA and tetrapolar BIA, across age and 
sex, when pre-testing guidelines were followed.   
Specific Aim 2: To examine the reliability of body composition estimates from a 
hand-held BIA at four pre-determined times during one free–living day.  These four body 
fat estimates during the free-living day helped determine variations in body fat 
measures when pre-testing guidelines are not followed. 
This chapter presents the results of this study.  The chapter will begin with the 
presentation of demographic characteristics of participants as a whole, by age group 
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and by sex.  Next results from the statistical analyses performed to address each of the 
specific aims will be presented.  Finally, the data will be summarized. 
 
Participants 
 A total of 116 individuals were screened to participate in the study, of which 96 
were eligible and 20 did not qualify.  Of the 20 individuals that did not qualify, five were 
disqualified due to age, four due to race other than White, five due to current diagnosis 
of a metabolic disease, five due to currently taking a medication or substance that 
would affect hydration status, and one female (age 55) did not meet the post-
menopausal inclusion criteria.  Of the 96 eligible, a total of 91 completed the study.  One 
participant was not able to complete the study due to not abiding by the pre-testing 
guidelines prior to the first laboratory visit.  The other four participants were not able to 
complete the study due to time constraints.  The final analysis included 91 men and 
women. 
Table 1 displays descriptive information for all 91 participants.  Slightly more 
females (55%) than males (45%) completed the study.  Participants ranged in age from 
19-39 and 55-75 years.   
 
 
 
       
68
 
Table 1.  Descriptive Characteristics of All Participants and by Sex. 
       
                  All (N=91)   Females (n=50)   Males (n=41) 
 
 
Mean SD Min Max 
 
Mean  SD Min Max 
 
Mean SD Min Max 
 Age (years) 42.4 17.3 19.0 75.0 
 
41.0 17.1 20.0 73.0 
 
44.1 17.6 19.0 75.0 
 Height (cm)** 171.8 8.7 153.8 190.0 
 
166.3 6.2 153.8 182.0 
 
178.5 6.3 161.5 190.0 
 Mass (kg)** 74.2 14.5 49.4 125.7 
 
67.1 10.4 49.4 101.2 
 
82.8 14.2 60.1 125.7 
 BMI (kg/m²)* 25.1 3.9 19.0 36.4 
 
24.3 3.9 19.0 34.7 
 
25.9 3.7 20.9 36.4 
 Waist Circ (cm)** 82.2 11.2 67.3 113.0 
 
76.9 8.9 67.3 106.4 
 
88.7 10.3 71.4 113.0 
 Hip Circ (cm) 101.4 8.3 87.6 124.2 
 
101.2 8.4 87.9 122.9 
 
101.7 8.1 87.6 124.2 
 Waist-to-hip ratio** 0.81 0.08 0.76 1.00 
 
0.76 0.05 0.68 0.91 
 
0.87 0.06 0.75 1.00 
 Arm span (cm)** 172.8 10.8 151.1 200.7   166.7 7.7 151.1 186.7   180.5 9.0 154.6 200.7 
 
 
                
 
 
 
 
Note.  * p < 0.05, significant differences between females and males, ** p<0.001, significant differences between females and males. 
BMI=body mass index, Circ=circumference.   
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Analyses were conducted to determine significant differences in descriptive 
characteristics between the female and male groups.  There were no significant 
differences in age (t(89)=-0.84, p=0.40) and hip circumference (t(89)=-0.32, p=0.75).  
There were significant differences in height (t(89)=-9.23, p<0.001), body mass (t(89)=-
6.10, p<0.001), BMI (t(89)=-2.02, p=0.046), waist-to-hip ratio (t(89)=-9.53, p<0.001), arm 
span (t(88)=-7.84, p<0.001), and waist circumference (t(89)=-0.32, p<0.001).  On 
average, males were 12.2 cm taller than females, 15.7 kg heavier than females, had a 
BMI 1.6 kg/m² higher than females, had a waist circumference 11.8 cm larger than 
females, had a waist-to-hip ratio (W:H) 0.11 more than females and an arm span of 13.8 
cm longer than females.    
Next, independent t-tests were conducted to determine differences between 
young and old groups for females and males.  Within the female group, there was no 
significant difference in height (t(48)=1.89, p=0.064), body mass (t(48)=0.58, p=0.576), 
BMI (t(48)=0.12, p=0.123), hip circumference (t(48)=0.12, p=0.118), and arm span 
(t(48)=1.59, p=0.119) between young and old female groups.  The difference between 
W:H between the young and old female groups approached significance (t(48)=-2.00, 
p=0.052).  The old female group had a waist circumference approximately 8% larger 
than young females (p=0.02), however, the mean waist circumference for both young 
and old female groups fell in the low risk category for cardiovascular disease (ACSM, 
2006).  A large range of BMI was present within both the young and old female groups.  
Body mass indexes ranged from Normal to Class 1 Obesity, with the mean BMI of the 
young females falling within the Normal classification, and the mean BMI of the old 
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female group falling in the Overweight classification (National Institutes of Health, 
1998).  Table 2 displays descriptive characteristics of all female participants and divided 
by young and old groups.  
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Table 2.  Descriptive Characteristics of Female Participants Displayed by Age Group. 
            Young (n=30)   Old (n=20) 
 
Mean  SD Min Max 
 
Mean SD Min Max 
Age (years) 27.7 5.1 20.0 39.0 
 
60.8 5.5 55.0 73.0 
          Height (cm) 167.6 6.0  158.0 182.0 
 
164.3 6.1 153.8 175.5 
          Mass (kg) 66.5 10.8  49.4 101.2 
 
68.2 9.8  54.2 87.3 
          BMI (kg/m²) 23.6 3.5  19.7 34.2 
 
25.4 4.4  19.0 34.7 
          Waist Circ (cm)* 74.6 6.9  67.3 97.5 
 
80.5 10.5  67.6 106.4 
          Hip Circ (cm) 99.6 8.2 87.9 122.9 
 
103.5 8.5 88.9 117.1 
          Waist-to-hip ratio 0.75 0.04  0.68 0.84 
 
0.78 0.06 0.71 0.91 
          Arm span (cm) 168.1 7.9  154.3  186.7   164.6 6.9  151.1 179.1  
 
 
Note.  * p < 0.05, significant differences between young and old groups. BMI=body mass index, 
Circ=circumference.   
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Differences between descriptive characteristics were also examined in the male 
group for both the young and old male groups.  There was no significant difference in 
height (t(39)=-0.67, p=0.506), mass (t(39)=-0.56, p=0.576), BMI (t(39)=-0.47, p=0.635), 
hip circumference (t(39)=-0.56, p=0.582) and arm span (t(39)=-0.27, p=0.788) between 
young and old male groups.  However, there was approximately a 10% higher W:H in old 
male group compared with the young male group (p=0.003).  The mean W:H for the 
young and old male groups fell in the normal range (18-59 years, W:H< 0.95; >60 years, 
W:H <1.03; ACSM, 2006) .  Additionally, the old male group had a waist circumference 
approximately 11% larger than young males (p<0.001).  The mean waist circumference 
for the young and old male groups fell in the low risk category for cardiovascular disease 
(ACSM, 2006).  Additionally, a large range in BMI was present within the young and old 
male groups.  Body mass index levels ranged from Normal to Class 2 Obesity, with the 
mean BMI of the young and old male groups falling within the Overweight range 
(National Institutes of Health, 1998).  Table 3 displays descriptive characteristics of the 
young and old male groups.   
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Table 3.  Descriptive Characteristics of Male Participants Displayed by Age Group. 
            Young (n=22)   Old (n=19) 
 
Mean  SD Min Max 
 
Mean SD Min Max 
Age (years) 28.8 5.2 19.0 39.0 
 
61.9 6.2 55.0 75.0 
          Height (cm) 177.9 7.1  161.5 190.0 
 
179.2 5.4 169.0 187.5 
          Weight (kg) 81.7 17.1  60.1 125.7 
 
84.2 10.3  70.4 104.8 
          BMI (kg/m²) 25.7 4.3  20.9 36.4 
 
26.2 2.8  21.9 31.0 
          Waist Circ (cm)* 84.5 11.7  71.4 113.0 
 
93.5 5.3  83.1 103.9 
          Hip Circ (cm) 101.1 9.8  87.6 124.2 
 
102.5 5.8  95.3 115.1 
          Waist-to-hip ratio** 0.83 0.05 0.75 0.95 
 
0.91 0.04  0.86 1.00 
          Arm span (cm) 180.2 8.2  163.2 200.7   181.0 10.2  154.6 198.1 
 
Note.  * p < 0.05, **p<0.001 significant differences between young and old groups. BMI=body mass 
index, Circ=circumference.   
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Summary  
 A total of 91 participants successfully completed the study, 50 females and 41 
males, between the ages of 19-75.  Of the females, 30 were in the young group and 20 
in the old group.  Of the males, 22 were in the young group and 19 were in the old 
group.  Overall, mean waist circumference and waist-to-hip ratio fell in the normal 
range or low risk for cardiovascular disease in both females and males (ACSM, 2006).  
There was a large range of BMI among female and male participants, ranging from 
Normal to Class 2 Obesity.  The mean BMI for the young female group fell in the Normal 
classification and the mean BMI for the old female group and the young and old male 
groups fell in the Overweight classification (National Institutes of Health, 1998).  Males 
were generally taller, heavier, had a larger waist circumference and longer arm span 
than females.     
 
Specific Aim 1: Validity of the Hand-Held Bioelectrical Impedance Analysis Device 
The goal of specific aim 1 was to compare body fat measures from the hand-
held BIA to a criterion measure of body fat (DEXA) and also to a like method of 
assessing body composition (tetrapolar BIA) across age and sex in a controlled setting 
when pre-testing guidelines have been followed.  It was hypothesized that BF results 
from the hand-held BIA would not significantly differ from DEXA or tetrapolar BIA 
measures during the controlled laboratory condition.  To address specific aim 1, a 
mixed between-by-within design comparing BF between sex and age groups (between 
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groups variables) and across hand-held BIA, tetrapolar BIA and DEXA measurements 
(within groups variable) was employed.  The main effect from these analyses will be 
presented first.  Two-way interaction will then be presented with simple main effects 
and post hoc comparisons where appropriate.  Finally three-way interactions will be 
presented.  
Results indicate that there was no significant main effect of device (F(1.3,103.8) 
= 2.30, p=0.13) meaning that, in the total group, there was no difference in %BF 
measures between the hand-held BIA, DEXA and tetrapolar BIA.  Despite a non-
significant main effect of device, the interaction between device and sex was significant 
(F(1.3,103.8) = 4.44, p=0.03) indicating that %BF was measured differently across 
devices for females and for males.  Results are presented in Table 4 and Figure 7.  In the 
female group, results showed there was a significant difference in BF estimates from 
the hand-held BIA as compared to DEXA (p<0.001) and from the tetrapolar BIA as 
compared to DEXA (p<0.001).  Specifically, the hand-held BIA underestimated %BF by 
2.7 percentage points compared to the DEXA.  The tetrapolar BIA also underestimated 
%BF by 2.5 percentage points compared to the DEXA.  There was no significant 
difference between the BF estimates from the hand-held BIA and the tetrapolar BIA in 
the female group (p=0.512).   
In the male group, the pattern of over and underestimation of the %BF by hand-
held BIA and tetrapolar BIA differed from the pattern in the female group.  There was a 
significant difference in %BF estimates between the hand-held BIA and the tetrapolar 
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BIA (p<.001), with the hand-held BIA overestimating %BF by 2.6 percentage points as 
compared to the tetrapolar BIA.There was no significant difference between the 
tetrapolar BIA and DEXA (p=0.07) and between hand-held BIA and DEXA (p=0.53).  
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Table 4. Mean Body Fat Measures Assessed by the Three Devices for Females 
(n=50) and Males (n=40). 
           BF DEXA (%)   BF HHBIA (%)   BF TBIA (%) 
 
Mean SEE 
 
Mean SEE 
 
Mean  SEE 
Females     32.2 1.2 
 
  29.5* 1.0 
 
29.7* 1.0 
Males 21.7 1.3    21.2** 1.2     18.6 1.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note.  *p<0.001, significant difference from DEXA;  **p<0.001, significant difference from 
TBIA.  BF=body fat, DEXA=dual-energy x-ray absoptiometry, HHBIA=hand-held bioelectrical 
impedance analysis, TBIA=tetrapolar bioelectrical impedance analysis 
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Figure 7. Mean Body Fat Measures Assessed by the Three Devices for Female and Male Groups 
(N=90). 
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Additionally, the two-way interaction between device and age (F(1.3,103.8) = 
12.92, p<0.001) was also significant, demonstrating that the %BF measures from the 
hand-held BIA and tetrapolar BIA were not consistent between young and old groups.  
In the young group, there was a significant difference in BF estimates from the 
tetrapolar BIA compared to DEXA (p<0.001) and from the hand-held BIA compared to 
DEXA (p<0.001).  Specifically, the hand-held BIA underestimated %BF by 3.5 percentage 
points compared to the DEXA.  The tetrapolar BIA also underestimated %BF by 3.8 
percentage points compared to the DEXA.  There was no significant difference between 
the BF estimates from the tetrapolar BIA and the hand-held BIA (p=0.13).  Results are 
presented in Table 5 and Figure 8. 
In the old group, the pattern of over and underestimation of BF by the hand-
held BIA and tetrapolar BIA differed from the pattern in the young group.  There was a 
significant difference in BF estimates from the tetrapolar BIA and the hand-held BIA 
(p<0.001), with the hand-held BIA significantly overestimating %BF by 1.9 percentage 
points.  There was no significant difference in BF measures in the old group between 
the DEXA and the hand-held BIA (p=.13) and the DEXA and tetrapolar BIA (p=0.38).  
Table 5 displays the means, standard deviations and standard error for the BF measures 
between the three devices for young and old participants.  Figure 8 plots differences in 
mean BF estimates for each device by age.   
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  BF DEXA (%)   BF HHBIA (%)   BF TBIA (%) 
 
Mean SEE 
 
Mean SEE 
 
Mean  SEE 
Young  25.2 1.4 
 
21.7* 1.0 
 
21.4* 1.1 
Old  30.5 1.4     31.1** 1.0      29.3 1.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note.  * p < 0.05, significant difference from DEXA; ** p<0.001, significant difference from 
TBIA.  BF=body fat, DEXA=dual-energy x-ray absoptiometry, HHBIA=hand-held bioelectrical 
impedance analysis, TBIA=tetrapolar bioelectrical impedance analysis. 
Table 5. Mean Body Fat Measures Assessed by the Three Devices for Young (n=58) and 
Old (n=32). 
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Figure 8. Mean Body Fat Measures Assessed by the Three Devices for Young and Old Groups. 
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There was no significant three-way interaction between device, age and sex 
(F(1.3,103.8) = 1.21, p=.29).    
The variables of BMI, waist circumference and arm span were examined as 
potential covariates in the model and tested for violations of assumptions.  No violations 
were detected and the variables were entered into the model.  Results indicate that 
there is no significant interaction between device and BMI (F(1.3,103.8) = 0.06, p=0.87), 
device and waist circumference (F(1.3,103.8) = 0.99, p=0.34), and device and arm span 
(F(1.3,103.8) = 0.59, p=0.48).   
 
Summary of Specific Aim 1 
Overall, results show that the hand-held BIA device is not statistically 
significantly different from DEXA for the male group and the old group, suggesting that 
the hand-held device is a valid tool for assessing body composition at a group level in 
these populations.  However, careful examination of Bland Altman Plots, which 
graphically depict the agreement between the DEXA and hand-held BIA for estimates of 
BF, displays a large range of agreement across individual participants (See Figures 10 
and 11).  Therefore, the hypothesis for specific aim 1 cannot be accepted for individuals 
in those two groups.      
Results also show that the hand-held device is statistically significantly different 
from the DEXA in the female and young groups, suggesting that the hand-held device is 
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not valid in these two groups for assessing body composition.  Therefore, the hypothesis 
for specific aim 1 was not accepted for the female and young groups.  Additionally, 
Bland Altman Plots show in the female and young groups the large range of agreement 
between DEXA and hand-held BIA (see Figure 12 and Figure 13).  Figure 9 displays 
means and standard error for the BF estimates from the three devices across age and 
sex.   
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Figure 10. Bland Altman Plot depicting agreement between estimates of body 
fat by DEXA and hand-held BIA in males (n=40). 
 
Note.  DEXA=dual-energy x-ray absorptiometry; HHBIA=hand-held bioelectrical impedance 
analysis.  Solid line represents mean body fat percent from DEXA and HHBIA.  Dotted lines 
represent 1.96 standard deviations from the mean.  Dashed lines represent clinically acceptable 
range of ±3.5%.  
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Figure 11. Bland Altman Plot depicting agreement between estimates of body fat by 
DEXA and hand-held BIA in the old group (n=38). 
 
Note.  DEXA=dual-energy x-ray absorptiometry; HHBIA=hand-held bioelectrical impedance 
analysis.  Solid line represents mean body fat percent from DEXA and HHBIA.  Dotted lines 
represent 1.96 standard deviations from the mean.  Dashed lines represent clinically acceptable 
range of ±3.5%.  
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Figure 12. Bland Altman Plot depicting agreement between estimates of body fat by 
DEXA and hand-held BIA in females (n=50). 
Note.  DEXA=dual-energy x-ray absorptiometry; HHBIA=hand-held bioelectrical impedance 
analysis.  Solid line represents mean body fat percent from DEXA and HHBIA.  Dotted lines 
represent 1.96 standard deviations from the mean.  Dashed lines represent clinically 
acceptable range of ±3.5%.  
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Note.  DEXA, dual-energy x-ray absorptiometry; HHBIA=hand-held bioelectrical impedance 
analysis.  Solid line represents mean body fat percent from DEXA and HHBIA.  Dotted lines 
represent 1.96 standard deviations from the mean.  Dashed lines represent clinically 
acceptable range of ±3.5%.  
 
Figure 13. Bland Altman Plot depicting agreement between estimates of body fat by 
DEXA and hand-held BIA in the young group (n=52). 
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Specific Aim 2: Reliability of the Hand-Held BIA Device 
Specific Aim 2 sought to examine the reliability of BF estimates from a hand-held 
BIA at four pre-determined times during one free–living day in the same population: 
immediately upon waking after voiding bladder, immediately after eating lunch, prior to 
bed and immediately after exercise.  It was hypothesized that significant variations in BF 
were expected during the free-living day demonstrating that, when pre-test instructions 
are not followed, BF results from the hand-held BIA may not be reliable.  Repeated 
measures analysis of variance (RM ANOVA) were performed on the hand-held BF 
measures to determine if there were differences in the hand-held BF measures over the 
duration of the free-living day and also with the controlled laboratory (LAB) hand-held 
BF measures.  Post-hoc comparisons were performed, where appropriate, to determine 
where specific differences in estimates of BF were present between the measurement 
times.  All participants completed three of the four free-living measures: after waking, 
after eating lunch and prior to bed. However, only 53 subjects participated in exercise 
on the assessment day and were, therefore, able to complete the fourth free-living 
measure that was taken immediately after exercise.  Results of the RM ANOVA including 
after waking, after eating lunch, prior to bed and LAB, indicate that there was a 
significant difference between the BF estimates performed over the course of the day 
and the LAB (F(2.82,236.97) = 13.51, p<0.001).  Post-hoc comparisons showed that there 
were significant differences between BF measures assessed in the LAB and waking 
(p<0.001) and LAB and prior to bed (p=0.008), with both free-living measure times 
underestimating the LAB measure.  There was no significant difference in BF measures 
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assessed in the LAB and after eating lunch (p=0.27).  Results suggest that the hand-held 
BIA device is not statistically reliable over the course of a day when pre-testing 
guidelines are not followed.  Results are presented in Table 6 and Figure 13. However, 
among the three free-living measure times there was only a difference of 0.2-0.8 
percentage points as compared to the LAB setting, indicating that the hand-held device 
is reliable over the course of one day. 
Because not all participants exercised, RM ANOVA was also performed using a 
subset of participants that completed all five measure times, the four free-living 
measures and the laboratory hand-held measure.  Results indicated that there was a 
significant difference across the five measurement times (F(2.95,141.78) = 6.92, 
p<0.001).  Post-hoc comparisons showed a statistically significant difference between 
the LAB and after exercise (p=0.004), specifically, with the measure after exercise 
underestimating that of the LAB measure.  However, among the four free-living 
measure times there was only a difference of 0.3-0.8 percentage points as compared to 
the LAB setting, indicating that the hand-held device is clinically reliable over the course 
of one day.  Table 6 displays mean BF measures over the free-living day for participants 
with four measures and participants with five measures.  Figure 14 displays changes in 
BF estimates over the course of the free-living day and also compared to the laboratory 
setting. 
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  4 Measure Times (n=88) 5 Measure Times (n=52) 
 
Mean SEE 
 
Mean SEE 
 LAB 26.1 0.9 
 
25.7 1.1 
 T1 25.4** 0.9 
 
24.9** 1.2 
 T2 25.9 0.9 
 
25.5 1.1 
 T3 25.2* 1.2 
 
25.3* 1.2 
 T4 — — 
 
25.2* 1.1   
 
 
 
 
 
 
Note. * p < 0.05 significant difference from LAB measure, ** p<.001 significant 
difference from LAB measure.  LAB=laboratory setting.  Four measure times: LAB, 
T1=after waking, T2=after eating lunch, T3=prior to bed.  Five measure times:  LAB;, 
after waking, after eating lunch, prior to bed, and T4=after exercise. 
 
Table 6.  Body Fat Measures Assessed by a Hand-held Bioelectrical Impedance 
Analyzer Over the Course of a Free-living Day. 
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Figure 14. Hand-held bioelectrical impedance analysis measures during 
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Summary of Specific Aim 2 
 Data from this study on 88 females and males between, the ages of 19-39 and 
55-75, demonstrate that the hand-held BIA device is not a statistically reliable device, on 
a group level, for estimating %BF over the course of a free-living day when hydration 
levels may be changing.  Significant differences were found between the LAB measure 
and after waking, before bed and after exercise.  No significant different was found 
between the LAB measure and after eating lunch, suggesting that after eating lunch may 
be the best time to take BF measures with the hand-held device.  Although the 
differences were statistically significant, they are not considered clinically significant in 
the group, with a difference range of only 0.3-0.8 percentage points.  Therefore, the 
hypothesis for Specific Aim 2 was not accepted.       
 
 
Summary 
 Data from this study on 91 female and male participants, ages 19-75 years, 
showed that the hand-held BIA device was a valid tool for assessing body composition in 
the male and old groups on a population level, however, not on an individual level 
which is the intended use of the product.  The hand-held BIA device was not a 
statistically valid tool for assessing body composition in the female and young groups on 
both a population level and an individual level.   
The hand-held BIA device was found to be not statistically reliable when 
estimating %BF over the course of one free-living day.  However, differences between 
BF measures over the free-living day were not clinically significant.  
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Chapter 5: Discussion 
 
 
Introduction 
 
  Many individuals have taken to self-monitoring body composition often using 
portable, inexpensive assessment tools given physician recommendations or their own 
desire to reduce body fat (BF).  Individuals use information about their body 
composition to help them make health-related decisions (e.g., dietary or physical 
activity changes, medications, medical procedures) and to track progress of an exercise 
or diet program, or other health intervention (Heyward & Wagner, 2004).  The 
purpose of this study was to evaluate the validity and reliability of a commercially-
available hand-held bioelectrical impedance analysis (BIA) device to estimate body 
composition for adults in a controlled laboratory condition and during a free-living 
condition.   
Results from this study have demonstrated that the hand-held BIA device was 
not a clinically valid tool for assessing body composition in the female, male, young and 
old groups.  Although the hand-held BIA device is valid for estimating %BF on a group 
level, the hand-held BIA device is marketed for and used by individuals.  Bland Altman 
plots displayed large ranges of agreement for all groups, indicating that the device is not 
valid on an individual level.  When examined on an individual level, only 52.8% of 
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females, 47.2% of males, 54.7% young and 45.3% old participants fell within the 
clinically acceptable range of ±3.5% from the criterion method.   
The hand-held BIA device was found to be not statistically reliable when 
estimating %BF over the course of one free-living day.  However, differences between 
BF measures over the free-living day were not clinically significant.  
This chapter begins by discussing the influence of sex and age on the validity of 
body composition measures from the hand-held BIA device.  The results are discussed in 
terms of their statistical significance as well as their clinical acceptability.  To address 
clinical acceptability, the minimal acceptable standard for estimating %BF is ±3.5% BF 
from the criterion measure (Heyward & Wagner, 2004) will be employed.  Next, the 
reliability of the hand-held BIA will be discussed.  The significance of these results, both 
from a scientific and a practical perspective will be addressed.  Limitations and 
assumptions of the current study will be outlined, and the impact of these limitations 
and assumptions on the results of this project will be reviewed.  Finally, 
recommendations for future research will be explained.   
 
The Influence of Sex on Validity of Body Composition Measures 
  It is well known that there are differences in body composition and body fat 
distribution between females and males.  When examining validity of the hand-held BIA, 
the results of the study showed that there were statistically significant differences 
between %BF estimations from the hand-held BIA and the criterion measure (DEXA) and 
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a like method (tetrapolar BIA) in the controlled laboratory setting across sex.  Results 
from this study show the HH BIA to be a statistically valid tool for assessment of body fat 
in males, but not females. 
Previous literature has investigated differences in hand-held BIA estimates of 
%BF when compared to a criterion measure in females and males.  However, previous 
research has used subject populations with different characteristics and some have used 
different models of hand-held BIA device.  Therefore, the published literature contains 
conflicting conclusions about the validity of hand-held devices for estimating %BF.  
One common theme among previous research is that the hand-held BIA device 
tends to be not only less accurate in females than males, but it tends to underestimate 
%BF more in females than males when compared to a criterion measure.  In the current 
study, the hand-held BIA significantly underestimated %BF by 2.7 percentage points 
compared to DEXA for the female group.  Although this was a statistically significant 
difference, this error falls within the clinically acceptable range (± 3.5%).  There was no 
statistically significant difference between the hand-held BIA and DEXA for the male 
group, with the hand-held BIA only underestimating DEXA by 0.5 percentage points.  
These findings were similar to other previously published hand-held BIA validation 
studies.  In a study focusing on a population of females and males similar in age to the 
young group of the current study, Weaver and colleagues (2009) examined the validity 
of the Omron HBF-306C and found results consistent with the current study.  They 
employed a similar study design and included similar pre-testing hydration controls.  
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The researchers found that the only significant difference in %BF output from the hand-
held BIA and the criterion measure was in women.  There were no statistically or 
clinically significant differences between %BF output from the hand-held BIA and the 
criterion measure in men.  Other researchers have found similar results.  Gibson and 
colleagues (2000) and Duz and colleagues (2009) found that the %BF results from a 
hand-held BIA device significantly differed from a criterion measure.  Both research 
groups found that the hand-held device, more often and to a larger degree, 
underestimated the body fat in women as compared to men.  Additionally, Esco and 
colleagues (2011) found that a hand-held BIA device underestimated %BF when 
compared to DEXA in a group of college female athletes by a mean of 5.1 percentage 
points.   Varady and colleagues (2007) showed that, in a group of 31 overweight women, 
%BF from a hand-held BIA device was significantly underestimated by a mean of 5.6 
percentage points when comparing to MRI as a criterion measure for assessing body 
composition. 
The common theme in this body of research is that the hand-held BIA tends to 
underestimate %BF in women to a greater extent than in men when compared to a 
criterion method.  It could be argued that because women tend to carry a larger portion 
of BF in the gynoid area and men tend to carry a larger portion in the android area, body 
geometry could affect the results of the hand-held BIA.  Hand-held BIA devices have to 
two handles that contain electrodes where the electrical current will be sent out via one 
electrode and received by the other electrode.  The electrical current flows through the 
upper body and may not accurately assess lower body fat (Lukaski, 2003).   
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The results also demonstrated that there were no significant differences in %BF 
estimates between the DEXA and hand-held BIA device and DEXA and tetrapolar BIA in 
the male group.  However, there were significant differences between the two BIA 
devices when estimating %BF in the male group.  Males tend to have less subcutaneous 
fat than women and carry more FM in the android region.  Having more centralized 
areas of BF could potentially influence the effectiveness of the whole body, tetrapolar 
BIA measure, as compared to a segmental hand-held BIA device.  The trunk of the body 
provides little impedance to the current flow as opposed to the limbs, therefore, 
centralized body fat may not be accurately assessed (S.B. Heymsfield, et al., 2005; 
Stevens, et al., 2010).  Additionally, BIA estimates TBW by way of electrical current 
through segments of the body and ultimately predicts BF and FFM.  Given the heavy 
reliance on water content within tissues, there could be a difference in the relative FFM 
in the total body and upper body in males as compared to females (Dehghan & 
Merchant, 2008).  Previous research has demonstrated that men have higher overall 
amounts of skeletal muscle than women, and sex differences are greater, specifically in 
the upper body (Janssen, Heymsfield, Wang, & Ross, 2000b).  Tetrapolar BIA is a whole 
body method that places electrodes on the right hand and right foot whereas the hand-
held BIA is a segmental device that only estimates TBW in the upper body (Kyle, 
Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et al., 2004).  If there are differences in 
FFM distribution in the total or upper body in males, the impedance values will differ 
within person between devices.   
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Lastly, another factor that could affect validity of estimations of BF and FFM 
from BIA devices in males is the prediction equation used to estimate percent BF or 
FFM.  For the hand-held and tetrapolar device, anthropometric and demographic 
variables are entered into the device prior to taking the measure.  Because the 
prediction equations used in the QuadScan 4000 tetrapolar BIA and the Omron HBF-
306C are proprietary, the equations are not known by the researcher.  Therefore, it is 
unknown how heavily weighted the factors impedance values and anthropometric 
measures are in the estimation of BF.       
Despite the numerous published studies where results are consistent with 
results of the current study, there is also some conflicting evidence to the current study.  
Deurenberg and Deurenberg-Yap (2002) conducted a validation study of the Omron BF-
306 hand-held body fat analyzer using a four-compartment chemical model as the 
reference method in female and male Chinese, Malay and Indian subjects.  Significant 
differences between %BF from the hand-held BIA and the reference method were found 
in Malay and Indian men, which is not consistent to findings in the current study that 
found no significant differences between DEXA and hand-held BIA estimates of %BF.  
The researchers also did not find a significant difference between the hand-held BIA and 
the reference method in females, which is also not consistent to the findings of the 
current study that found significant difference between the criterion measure (DEXA) 
and the hand-held BIA measure for females.  A possible reason for different findings 
could be due to the fact that the participants were not given similar pre-testing 
instructions to control for hydration status as the current study.  The published results 
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do not state any control for hydration.  Bioelectrical Impedance Analysis devices assess 
TBW from which an estimate BF or FFM is calculated (Kyle, Bosaeus, De Lorenzo, 
Deurenberg, Elia, Gomez, et al., 2004).  Total body water is assessed by impedance to 
the flow of an electrical current that is measured as an electrical current passes through 
the body between two electrodes on the hand-held device.  The voltage drop in 
electrical current between electrodes is due to the impedance of the current flow.  Body 
composition is estimated based on the principle that electrical current flows with less 
impedance in areas that have high water and electrolytes, such as skeletal muscle, 
compared to less hydrated tissues such as adipose tissue (Esco, et al., 2011a).  
Therefore, if the participants were not normally hydrated, the estimations of BF and 
FFM can be skewed, with those who are overhydrated having lower impedance values 
and those who are dehydrated having higher impedance values.  Second, because there 
are known differences in body composition among different racial groups, those 
differences may introduce observed bias when using prediction equations from a hand-
held BIA device that were validated on mostly White, European subjects.  The 
population used in the study consisted of all Asian participants, who have higher body 
fat percentage on average compared to Whites (Wulan et al., 2009).  Wang et al. (2000) 
also reported lower hydration of FFM in Asian individuals, which would result in higher 
impedance values as compared to White individuals.  Furthermore, there are also 
differences in body fat percent between regions of Asia, such as Chinese, Indian and 
Malay individuals, which could increase observed bias (Wulan, Westerterp, & Plasqui, 
2012).   
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Erceg and colleagues (2010) also found conflicting results to the current study.  
In a racially diverse sample of 128 females and 117 males, ages 18-80 years, they found 
no significant differences in %BF estimates from the Stayhealthy BC1 hand-held device 
as compared to the DEXA in the female or male groups.   Whereas, the current study 
found that there were statistically significant differences between the BF measures from 
the hand-held as compared to the DEXA.  They concluded that the hand-held BIA device 
is a valid tool for estimating BF among both groups.  One potential reason for the 
contradictory results to the current study is that the Stayhealthy BC1 hand-held device 
may have different proprietary prediction equations for estimating %BF in males and 
females as compared to Omron models of hand-held BIA devices.    
 In summary, sex played a significant role in the validity of the hand-held BIA 
device.  Body fat measures from the hand-held BIA were not significantly different 
compared to BF measures from DEXA in the male group.  Although there was a 
statistically significant difference in BF measures from the hand-held BIA as compared to 
DEXA for the female group, the underestimation of 2.7 percentage points is not clinically 
significant.  Therefore, the hand-held BIA could be considered a valid device for 
estimating BF in female and male groups on a population level.  However, Bland Altman 
plots display a large range of agreement for both females and males, indicating that the 
device is not valid on an individual level.  The smaller the range between these two 
limits the better the agreement is.  That definition depends on the clinical acceptance 
standard for the method, which in this case is ±3.5%.   
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The Influence of Age on Validity of Body Composition Measures 
It is well established that BF increases with age and FFM declines with age (Kyle 
et al., 2001); therefore, it is important to have valid devices to estimate body 
composition across the life span.  This study found that age significantly influenced the 
validity of the hand-held BIA compared to DEXA in the young group but not in the old 
group.  
There are conflicting results from previous research on the validity of a hand-
held BIA device as it relates to age.  However, few studies have included older adults in 
the population samples.  Furthermore, of those that included older adults, none made 
direct comparisons between young and old groups.  Based on the lack of information on 
validity of hand-held BIA between young and old groups, drawing conclusions may be 
difficult.   
There are many factors that could potentially affect the validity of the hand-held 
BIA device in estimating %BF in the young group as compared to the old group.  In the 
young group, there was a statistically significant underestimation of BF as compared to 
DEXA.  Even more, the difference was 3.5 percentage points, which is at the limit for 
clinical significance.  Younger adults tend to have more subcutaneous fat and less arm 
fat than older adults (Kuscmarski, 1989; Deurenberg & Deurenberg-Yap, 2002).  
Therefore, less arm fat in young adults will record in lower impedance values, which will 
result in lower BF estimates in young adults by the hand-held BIA device.   
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In the old group, there was no statistically significant difference between DEXA 
and the hand-held BIA; however, there was a significant difference between the two BIA 
devices.  There are a few potential reasons why different types of BIA devices could 
estimate BF differently in the old group.  Older adults tend to have less subcutaneous 
fat and carry more FM in the android region as compared to young adults (Kuczmarski, 
1989).  Having more centralized areas of BF could potentially influence the effectiveness 
of the whole body, tetrapolar BIA measure, as compared to a segmental hand-held BIA 
device (Stevens, et al., 2010).  As previously mentioned, the trunk of the body provides 
much less impedance to the current flow than the limbs, therefore, centralized body fat 
may not be accurately assessed (S.B. Heymsfield, et al., 2005; Stevens, et al., 2010).   
Additionally, as adults age, there is an increase in intramuscular fat and arm fat 
(Deurenberg & Deurenberg-Yap, 2002b).  This will affect the ratio of fat and TBW in the 
arms, which can affect the impedance values.  Body composition is estimated based on 
the principle that electrical current flows with less impedance in areas that have high 
water and electrolytes, such as skeletal muscle, compared to less hydrated tissues such 
as adipose tissue (Esco, et al., 2011a).  Therefore, if the hand-held BIA is measuring 
impedance only in the arms and upper body, impedance values may be different from a 
whole body tetrapolar BIA measure that assess lower body, trunk and arms.   
Lastly, the differences in criterion measure from the original validation of the 
device compared to the current study could potentially have an effect between the 
young and old groups.  The Omron HBF-306C was originally validated against both HW 
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and DEXA, whereas, the current study only used DEXA as the criterion method.  When 
assessing body composition with HW, an assumption is made that there is no difference 
in densities of FFM across all individuals (Wagner & Heyward, 1999).  However, there 
are known differences in BF and FFM in young and old adults, therefore, the method is 
only as good as the conversion formula employed (Kyle, et al., 2001).   
In summary, age played a significant role in the validity of the hand-held BIA 
device to accurately estimate %BF in the current study.  There was a statistically 
significant difference between DEXA and hand-held BIA in the young group.  This 
significant difference was also nearing a clinically significant difference, with an 
underestimation of %BF by the hand-held BIA by 3.5 percentage points.  There was no 
significant difference between the %BF estimates between DEXA and hand-held BIA for 
the old group.  Therefore, the hand-held BIA would be considered a valid device, on a 
population level, for these two groups.  However, Bland Altman Plots visually suggest 
large ranges of agreement between DEXA and the hand-held BIA, suggesting that the 
device is not valid on an individual level for young or old groups.   
 
Influence of Body Fat Level on the Validity of the Hand-held BIA Device 
One finding from this study that is consistent with previously published 
validation studies is that the hand-held BIA tends to underestimate %BF as mean BF 
increases and overestimate %BF as mean BF decreases.  In the current study, this trend 
was found in both the young and old groups.  Weaver and colleagues (2009) 
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demonstrated similar over- and underestimations among a group of individuals aged 18-
32 years, similar to the young group of the current study.  Esco and colleagues found 
that in young females, the hand-held BIA significantly underestimated %BF as compared 
to the DEXA as mean BF increased.  Lukaski and colleagues (Lukaski & Siders, 2003) 
found that both hand-held and foot-to-foot segmental BIA devices significantly 
underestimated %BF as total body fat increased in a group of individuals ages 18-60 
years.  Finally, Duz and colleagues found, in both men and women, that the hand-held 
BIA significantly underestimated %BF as mean BF increased in a group of young, healthy 
adults.  This difference in under- and overestimating BF for extremely lean and obese 
individuals is due to regressing each individual to the mean BF within the prediction 
equation.  Equations are not meant to predict extremes, rather, are created to predict 
something that is more central to the mean.  Therefore, those that are overfat tend to 
have an underestimation of BF by the hand-held BIA and those that are underfat tend to 
have an overestimation of BF by the hand-held BIA.   
In contrast, Erceg and colleagues (2010) did not find this trend in their subject 
sample as a whole, with age ranges from 18-80y.  However, they used a different make 
and model of a hand-held BIA device than the current study which may use different 
technology and different prediction equations when estimating %BF.   
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Reliability of the Hand-Held BIA Device in Assessing Body Composition 
The ability of a body composition assessment device to provide consistent 
estimates of body composition over the course of a day or between days is very 
important when using the device to determine change, or lack of change, in body 
composition.  There are very few studies that have examined the reliability of hand-held 
BIA devices to estimate body fat levels after an event where hydration is expected to 
change in a single day (Weaver, 2009) and over the course of multiple days (Lukaski et 
al., 2003).  Results of these two studies are not consistent, with one showing the device 
is reliable, and one demonstrating the device is not reliable.  This study aimed to build 
on the limited published literature and address the question of reliability within day 
using a novel concept in assessing changes in BF output based on different times of a 
free-living day when hydration level may vary in individuals in the entire subject sample.  
It was hypothesized in the current study that significant variations in BF were expected 
during the free-living day demonstrating that, when pre-test instructions were not 
followed, results may not be reliable and should not be used to make-health related 
decisions. 
In the current study, the only factor that had a statistically significant interaction 
with the %BF output by the hand-held device was the time of measure.  It was found 
that there were statistically significant differences between BF measures from the LAB 
and three of the free-living measure times: after waking and voiding bladder, prior to 
bed and immediately after exercise.  No significant difference was observed between 
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the LAB measure and after eating lunch during the free-living day.  Although the current 
study found statistically significant differences in BF estimates during the free-living day 
as compared to the LAB, those differences were minimal and fall within a clinically 
acceptable range.   
The hand-held device is a popular method to assess BF in health clubs, where 
clients often chose to self-assess their BF prior to or after exercise.  It is important to 
note that after a bout of exercise, TBW would be expected to change, therefore, 
potentially altering %BF estimates from a hand-held BIA device.  In the current study, 
there was a statistically, but not clinically, significant difference between the controlled 
LAB measure and after exercise measured during the free-living day.  This current 
finding was also consistent with the finding reported by Weaver and colleagues (2009) 
when examining the changes on %BF measures from a hand-held BIA device during a 
controlled laboratory setting when pre-testing guidelines compared to after a 30 bout of 
exercise.  They found that body fat decreased significantly by 0.3 percentage points 
post-exercise indicating there was no clinically significant difference.  These findings 
suggest that hydration status or TBW may not be heavily weighted in the propriety 
prediction equation used to estimate %BF with a hand-held BIA device.  Based on the 
findings of the current study, it is concluded that hydration status does not play a large 
role in the prediction equation of the Omron HBF-306C device, therefore, these factors 
do not significantly affect the %BF output from the device.    
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 Because the prediction equation used in the Omron HBF-306C to estimate BF is 
proprietary, how different variables are weighted in the equation is unknown.  Prior to 
assessing BF using the Omron HBF-306, individuals must enter their height, mass, age 
and sex.  In previously published prediction equations for healthy adults, the most 
common variables include sex, age, stature (height), weight (mass) and resistance (Kyle, 
Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et al., 2004; Sun et al., 2003).  There are 
also previously validated equations for specific groups and ethnicities that may not be 
valid for the general population (Kyle, Bosaeus, De Lorenzo, Deurenberg, Elia, Gomez, et 
al., 2004).  Each validated and published BIA prediction equation places more emphasis 
on certain variables and less on others.  The results of the current study suggest that 
hydration status or impedance values may not be heavily weighted in the proprietary 
prediction equation in the hand-held BIA device.  Other factors that could potentially 
cause changes in hand-held BIA %BF over the free-living day include skin temperature, 
skin integrity, correct placement of hands on the electrodes and proper arm abduction 
and straightness when taking the measure.  However, the current study did not control 
for these variables.  Participants were given instructions about placement of hands and 
arms while using the hand-held BIA device, but it was not monitored.   
In addition to these findings, Lukaski and Siders (2003) found large day-to-day 
variations in %BF measures over a five day period with the Omron HBF-301 hand-held 
BIA device.  They randomly selected 10 of the 110 participants to monitor BF over the 5 
day period to determine how much variation would occur.  There is no mention of time 
of day the measures were taken or if there was any control for hydration status.  They 
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found that with body mass only changing by approximately 1% over the five days, that 
the estimated BF had a variation of 2-10% over the five days.  They concluded that the 
ability to monitor BF over time and changes in body fat is still in question.  The current 
study found no clinically significant differences over the course of the day; however, 
these results indicate that, possibly, over a longer period of time, the hand-held device 
may not be reliable in estimating BF.  Further investigation is needed to determine 
reliability of the hand-held device over days, weeks or months. 
The current study found that there are statistically significant differences in %BF 
measures with the hand-held BIA over the course of a free-living day when compared to 
the LAB measure.  Only one measurement time during the free-living day was not 
statistically significant; after eating lunch.  However, the statistically significant 
differences are small, 0.2-0.8%, and fall within a clinically acceptable range.  The main 
finding is that the hand-held device is clinically reliable in estimating %BF over the 
course of a free-living day.  However, this study did not investigate the reliability over 
days or weeks and these results cannot be used to indicate changes in body composition 
over time.     
Significance 
Scientific Significance 
When examining the validity and reliability of a hand-held BIA, numerous gaps in 
the literature exist.  The results of this study add to the literature by addressing some of 
those gaps. 
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 The first gap in the literature is the knowledge of the validity of the hand-held 
BIA in estimating BF across sex.  Previous research has investigated these relationships; 
however, conflicting results have been documented (Deurenberg & Deurenberg-Yap, 
2002; Erceg et al., 2010; Weaver et al., 2009).  The amount of BF and BF distribution is 
most often different between men and women, and it is important to determine if those 
differences alter the validity of the device.   
The findings also add to previous literature because there is a gap in information 
and knowledge on the accuracy of hand-held devices across a large age span.  Most of 
the previous research has been completed using young adults, rarely including subjects 
over the age of 60 (Deurenberg & Deurenberg-Yap, 2002; Erceg et al., 2010).  This is 
important because of the changes in FM and FFM as adults age.  These changes in FM 
and FFM pose a challenge when selecting a body composition method to accurately 
assess differences between young and old groups.    
Additionally, only one of the previous studies on hand-held BIA devices has 
controlled for hydration using all of the ACSM pre-testing guidelines (Weaver et al., 
2009).  It has been documented that hydration and TBW play a large role in the ability of 
BIA devices in estimating BF (Kyle et el., 2004).  Based on the results of the current 
study, it may not be necessary to abide by the pre-testing guidelines when using the 
hand-held BIA as a measure of body composition in a group.   
 There is also a lack in information about the reliability of hand-held devices in 
estimating %BF, especially within one day.  Only two published studies have examined 
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the reliability of the hand-held BIA in estimating %BF during times of hydration changes, 
and have found conflicting results (Weaver et al., 2009; Lukaski & Siders, 2003).  The 
current study adds a novel component of a free-living situation to assess the reliability 
over time and across changes in hydration status.   
  
Practical Significance 
 Because the Omron HBF-306C BIA is commercially available it could be 
purchased by any individual interested in self-monitoring or changing their body fat 
level.  Individuals may use the results from this device to make health-related decisions 
such as modifying a diet or exercise program or altering medications that may affect 
body weight or body fat.  If individuals are not receiving accurate BF results, they may 
elect to alter their lifestyle or diet in a way that may be detrimental to their health.  
Although the current study’s results indicate that the device is a valid and reliable tool 
for assessing BF, there is still some concern about the validity on an individual level.  
There is a high level of disagreement between the hand-held BIA and the criterion 
method of DEXA, indicating that the two methods do not provide similar measures and 
should not be used interchangeably.        
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Assumptions 
 There were three main assumptions for this study.  First, it was assumed that all 
participants were honest when answering screening questions to determine eligibility 
for study participation.  Second, it was assumed that all participants followed the pre-
testing guidelines prior to the first lab visit for the body composition assessments.  
Third, it was assumed that, during the free-living day, all participants followed the study 
instructions given to them at the first Laboratory visit, were gripping electrode properly 
and were honest when recording their %BF from the hand-held BIA throughout the day.   
 
Limitations 
 No study is without limitations.  This study contained a few limitations that 
should be considered when interpreting and applying the results.  First, the results are 
only generalizable to a similar population studied within this project, a population that 
was free of any disease or medication that can alter hydration status and between the 
ages of18-39 years or 55-75 years of age.  Additionally, because of the known 
differences in body composition between races, the results of the current study can only 
be generalizable to White individuals.  Lastly, there was no control for menstrual cycle in 
the female group; however, previous research has demonstrated that there are not 
significant changes in TBW during a female’s menstrual cycle (McKee and Cameron, 
1998).  
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Future Research 
 This study provided results that added to the current body of knowledge 
focusing on BIA technology, specifically hand-held BIA technology.  From these results, 
however, a number of additional questions were generated.  Results demonstrated that 
the hand-held device was statistically valid in adults ages 55-75 but not for adults ages 
18-39.  Changes in body composition with age play a role in the validity of the hand-held 
device and should be explored.  Due to differences in body composition between race, 
future research should investigate the validity and reliability of the hand-held device 
among races other than White.  Many researchers have developed BIA prediction 
equations for specific ethnic groups; therefore, it is known that ethnic differences BIA 
devices to estimate BF.  The Omron HBF-306C does not have an input for ethnicity; 
therefore, ethnicity is not accounted for when predicting body fat level.  If future 
research demonstrates that the device is only valid within White individuals, then it is 
important the prediction equations be created for use by other ethnicities. 
Because the results suggested that the hand-held BIA device is only reliable over 
the course of one day, future research should focus on reliability of the device across an 
extended period of time.  Additionally, it may be worth investigating if the BIA device is 
also reliable with fluctuations in body mass over time.  Results also indicated that the 
hand-held BIA device was only valid after eating lunch, which is not a recommended 
time for BIA measures (ACSM, 2006).  Future research could focus on the reliability over 
time to investigate if that is the optimal time to take the BF measures.    
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 There are also some technical limitations to the current device.  The device is 
only able to estimate body fat between 4-50%.  Future research could focus on new 
devices or prediction equations that can accurately assess BF in those that are extremely 
lean or excessively obese.  Due to health complications that can arise from both of those 
extremes, it is important that those individuals are able to accurately estimate body fat 
to make necessary health-related decisions.     
 
Final Conclusion 
 The main finding of the current study is that, according to clinical standards, the 
Omron HBF-306C is a valid device for estimating %BF across age and sex on a population 
level.  Although there were statistically significant differences between %BF measures 
from the hand-held BIA device and DEXA for the females and young groups, that 
difference falls within the minimal clinically acceptable standard for estimating %BF of 
±3.5% BF from the criterion measure (Heyward & Wagner, 2004).  However, the validity 
results must be viewed with caution when estimating %BF on and individual level, which 
is the marketed use of the product.  Examination of Bland Altman Plots depicts large 
ranges of agreement between the BF estimates from the hand-held BIA and the DEXA in 
all groups: female, male, young and old.  Therefore, the hand-held BIA device is not a 
valid tool for assessing BF on an individual level.  It is important to note that sex and age 
were the only two variables that impacted the validity of the hand-held BIA device as 
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compared to the DEXA and tetrapolar BIA.  There was no interaction with device and 
arm span, waist circumference and BMI.   
 Additionally, the Omron HBF-306C is a reliable device for estimating %BF on a 
population level over the course of one day.  Although there were some statistically 
significant differences in %BF estimates from the free-living day compared to the LAB 
measure, the differences were not clinically significant.  Future research is warranted for 
reliability over multiple days, weeks or months.   
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CALL LOG:  DATE/ TIME                     COMMENT 
 
Hello, my name is _____________ and I am a________________ working with the 
Physical Activity & Health Research Laboratory at the University of Wisconsin- 
Milwaukee.  You have indicated that you are interested in participating in physical 
activity research with our Lab.  If you have a moment, please let me tell you about a 
study that we are currently working on.  It is a study designed to examine the validity of a 
hand-held body fat analyzer.  Before I tell you about the study, do you mind if I ask you a 
few questions about yourself to determine if you qualify for the study. 
 
1. What is your current age?_______________  Date of birth: ________________ 
*The individual qualifies if aged 18-40 and 50-75 years.  
2. What is your gender:     M F 
3. What is your ethnicity:  ____________________  *Individuals qualifies if white. 
4. Are you currently pregnant, think you could be pregnant or nursing?  Yes  No 
5. Have you been diagnosed with congestive heart failure, cardiomyopathy disease, 
heart valve disease or have a pacemaker?     Yes  No 
6. Have you been diagnosed with any pulmonary disease such as Chronic Obstructive 
Pulmonary Disease?        Yes  No 
7. Do you have a metabolic disease such as diabetes or thyroid disease?  Yes  No 
8. Have you ever been diagnosed with Cirrhosis or kidney disease?   Yes  No 
9. Are you currently taking a diuretic medication, calcium channel blockers or other 
substance that would affect hydration status of the body?   Yes  No 
10. Have you had a barium or nuclear medical test within the past week?  Yes  No 
 
11. Please self-report your height and weight: 
Physical Activity & Health  
Research Lab 
Department of Human Movement Sciences 
Enderis Hall, Rm. 434 (414)229-4392 
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Height: ________      Weight:_______ 
 
***They are eligible to participate if: 
 
 INDIVIDUAL ANSWERS “NO” TO QUESTIONS ABOVE 
 IS BETWEEN 18-40 and 50-75 YEARS  
 
IF THEY QUALIFY… 
 
You are one of 120 men and women who are being asked to participate in this study at 
the Physical Activity & Health Research Laboratory of the University of Wisconsin-
Milwaukee.  This research study will consist of two laboratory visits separated by one 
unsupervised free-living day 
 
Visit 1: 
On the day of your first visit, you will report to the Physical Activity & Health Research 
Laboratory.   A pregnancy test will be conducted for all female participants prior to any 
assessments.  If you are pregnant or nursing or trying to become pregnant, you will not be 
able to complete portions of the study, and therefore, are ineligible. We will ask you to 
provide us with some information on your current and previous health.  Additionally, we 
will ask you to complete five pen and paper questionnaires.  Next, measures of resting 
heart rate and blood pressure as well as anthropometric measures of body weight, 
standing height, arm span, and waist and hip circumference measures will be taken.  You 
will then have their body fat measured by three separate devices: tetrapolar bioelectrical 
impedance analysis (BIA), dual-energy x-ray absorptiometry (DEXA), and a hand-held 
BIA.  Following BIA guidelines, you will rest supine for five minutes, after which body 
fat levels will be assessed using the tetrapolar BIA, followed by a DEXA scan.  After 
completion of the supine body fat measures, you will be asked to stand where two 
consecutive body fat measurements will be completed with the hand-held BIA.  Once 
body fat measures are completed, you will receive detailed verbal and written instructions 
on how to use the hand-held BIA for the free living day, including specific times of the 
day to take and record BF measures.  In addition, you will be given instructions on the 
proper wear of a physical activity assessment device that you will wear for the free-living 
day as well as instructions to record body fat readings from the hand-held BIA that will 
be completed during the free-living day.   
   
 
Free-living Day:  
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You will bring home the Omron HBF-306C hand-held BIA device.  Within 72 hours of 
the laboratory visit, you will be asked to assess BF via the Omron HBF-306C device at 
specific times of the day: 1) immediately upon waking and voiding bladder, 2) 
immediately after eating lunch, 3) right before going to bed, and 4) immediately after 
exercising (if exercise was done during the day) all within one 24 hour time period.  In 
addition, you will wear the physical activity assessment device during the same 24 hour 
time period and complete a daily event log for all activities performed during that time as 
well as any food, beverage or medications ingested.   
 
Visit 2: 
Within 48 hours of the free-living day, you will return the hand-held BIA device to the 
laboratory where they will be provided with results from their DEXA and tetrapolar BIA 
measurements.  You will be asked to complete five questionnaires after receiving your 
DEXA and tetrapolar BIA measurements.   
 
Just a few more questions… 
1. Is there any reason why you cannot complete this study?     
 Yes   No  
2. Do you have any medical conditions or vacations scheduled which would 
interfere with completion the study.        
  
 Yes   No  
 
Are you still interested?    IF YES, SCHEDULE THEM FOR THE STUDY 
 
 
IF THEY DO NOT QUALIFY… 
Unfortunately, due to __________________ you do not qualify to participate in this 
project at this time.  If you would like to be contacted in the future for  
other studies taking place in the Physical Activity and Health Research 
Lab, I would can keep your name on file.  Would you like to hear about 
such studies in the future?      
       
     Yes    No 
 
 
Initials and date of person who filled out this form____________________________ 
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UNIVERSITY OF WISCONSIN – MILWAUKEE 
CONSENT TO PARTICIPATE IN RESEARCH 
 
1. GENERAL INFORMATION 
 
Study title: Validation of hand-held bioelectrical impedance analysis for the assessment 
of body fat in young and old adults. 
 
Person in Charge of Study:  
Ann M. Swartz, Ph.D. 
Associate Professor 
Department of Human Movement Sciences 
University of Wisconsin – Milwaukee 
 
2. STUDY DESCRIPTION 
 
Study description: 
The primary purpose of this study is to examine the accuracy of a hand-held body fat 
analyzer.  You will be one of 120 White individuals (18-39yrs or 55-75yrs) participating in 
a research study at the Physical Activity and Health Research Laboratory of the 
University of Wisconsin-Milwaukee.  The study will be conducted over two visits, 
separated by one free-living day (24 hours).   The free-living day must be completed 
within 72 hours of the first laboratory visit.  The first laboratory visit will last 
approximately one hour and 15 minutes.  During the first visit, a pregnancy test will be 
conducted prior to any assessments.  If you are pregnant or nursing or trying to become 
pregnant, you will not be able to complete portions of the study, and therefore, are 
ineligible.  You will be asked to complete a questionnaire on your current and previous 
health history, as well as demographic information.  You will be asked to complete an 
additional six, short questionnaires and have your height, weight, waist and hip 
circumference, arm span, bone mineral density, and body fat assessed.  During the free-
living day you will be asked to measure and record your body fat using a hand-held body 
fat analyzer four times in one day, and wear a physical activity assessment device.  After 
completion of the free-living day you will be asked to return to the laboratory for your 
final visit.  At the final visit, you will return the hand-held body fat device and be given 
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the results of the bone mineral density and body fat assessments.  Following this, you 
will be asked to complete six, short surveys.  Participation in the research study is 
completely voluntary, and you do not have to participate if you do not want to. 
 
3. STUDY PROCEDURES 
 
What will I be asked to do if I participate in the study? 
This research study will consist of two visits to the Physical Activity and Health Research 
Laboratory of the University of Wisconsin-Milwaukee separated by one unsupervised 
free-living day.   The free living day must be completed within 72 hours of the first 
laboratory visit.  
 
Lab Visit #1 (approximately 1 hour and 15 minutes in duration) 
Pre-Visit Instructions 
Prior to attending the fist lab visit, you will be given the following pre-visit guidelines via 
telephone and/or email, depending on your communication preference: 
 Do not consume alcohol 48 hours before laboratory visit 1 
 Do not consume products with diuretic properties (caffeine, chocolate) for 24 
hours before laboratory visit 1 
 Do not exercise 12 hours immediately before laboratory visit 1 
 Do not eat or drink anything except water 4 hours immediately before laboratory 
visit 1 
 We will ask you to void your bladder 30 minutes prior to the body fat assessments 
 
On the day of your testing session, you will report to the Physical Activity and Health 
Research Laboratory. At the time of this visit you will be given an introduction to the 
study.   
 
Pregnancy Test 
In order to ensure that you are not pregnant for the body composition assessments, we 
will ask you to perform a pregnancy test if you are a woman of child-bearing age.  You 
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will be escorted to a nearby restroom for completion of this test.  You will be provided 
with a stick for the pregnancy test.  You will be asked to remove the cap of the stick and 
hold the stick in your urine stream.  You will then recap the stick,  and give it to the 
researcher.  The researcher will place it in a plastic bag and escort you back to the lab. 
The pregnancy test will then be placed on a horizontal surface for 5 minutes, afterwhich 
the results will be available.  If the stick shows one line, this will indicate that you are 
NOT pregnant.  If the stick shows 2 lines, this indicates that you ARE pregnant (positive 
test).  If this test confims a pregnancy, we will discontinue your participation in the 
study, and  will provide you with some educational information from Norris Health 
Center about pregnancy and refer you to your family physician. According to the 
manufacuter, this test is 99.9% accurate.  
 
Demographic Measures 
You will be asked to complete a questionnaire on your current and previous health 
status and demographic information.  These measures will be completed in order to 
gather necessary information to ensure that you meet the inclusion/exclusion criteria 
for this study.  
Questionnaires 
You will be asked to complete six questionnaires.  The information from these 
questionnaires will help to create a better overall description of the research 
participants in the study. The first three questionnaires will be used to assess your 
motivation to change your exercise habits, your calorie and fat intake, and your weight.  
These questionnaires range in length from one to four questions.  The next 
questionnaire will be used to assess your satisfaction with various parts of your body.  
This is a 9-item questionnaire using a Likert scale.  You will be asked how strongly your 
agree or disagree with various statements about your body.   Another questionnaire will 
assess anxiety about your physical appearance.  You will be asked to answer each 
question based on how you are feeling at the current moment.  The final questionnaire 
consists of questions asking you to provide your estimate or opinion about  your body, 
your body weight, the amount of fat within your body, how your levels rank compared 
with other women your age. This questionnaire will also include questions regarding 
whether you have had your body fat measured before and with what method(s) or 
tool(s).  It will take approximetly 10-15 minutes to complete these surveys, and it is 
important to take your time with the surveys and answer each question honestly and 
completely. 
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Baseline Measurements 
You will have your height, weight, arm span and the distance around your waist and hips 
measured.  We will measure resting blood pressure and heart rate.  To measure blood 
pressure, we will place a cuff around the upper right arm.  This cuff will be inflated with 
air, and then slowly let down again.  By listening to the sound of the pulse in the arm we 
are able to determine a blood pressure reading.   
Body Fat Measure 1  
We will measure your body fat with a tetrapolar bioelectrical impedance analysis (BIA) 
device (Bodystat® Quad Scan 4000; Douglas, Isle of Man).  You will be instruted to lay 
still on the padded table and your body will be positioned properly for the 
measurement. After five minutes of rest, the back of your right hand and the top of your 
right foot will be cleaned with an alcohol pad.  Once your skin has dried, two stickers will 
be placed on the back of the right hand and two on the top of the right foot.  The 
technician will attach the cords from the body fat measuring device to the electrode 
stickers and will administer the test.  This test will take approximately one minute.  A 
very low frequency current is sent from electrode to electrode in the hand and foot and 
body fat will be estimated.  This test is included solely for research purposes.  This is a 
non-invasive, safe, and painless procedure.   
Body Fat Measure 2  
The second measure of body fat, will consist of assesment with a dual energy x-ray 
absorptiometer or DEXA scan. We will be using this device to measure your body fat 
level, but it will also measure the strength of your bones (bone mineral density).  At the 
end of the study we will provide you with the results from this measure, which will 
include your body fat level and the strength of your bones.   This is a common and 
painless procedure that involves lying still on a padded table for approximately 10 
minutes while the machine takes an x-ray picture of your whole body. During the test 
you will be able to breathe normally. Because the test involves taking an x-ray picture of 
your body, you will be exposed to radiation.  However, the amount of radiation used for 
this test is very low. It is about the same amount one would get on a long plane flight 
(from New York to Los Angeles) and much less than one is exposed to during a typical 
chest x-ray.  This test is included solely for research purposes and is not considered part 
of your standard clinical care.  Please do not wear clothing with any metal (buttons, 
snaps, or zippers) on the day of the test. If you do wear metal, we will ask you to remove 
it for the test.  If you have recently had x-ray tests using barium or any nuclear medicine 
tests, you should have your DEXA scan performed at least a week after those tests.  
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Body Fat Measure 3 
Body fat will be estimated using a third device, a hand-held bioelectrical impedance 
analysis, or BIA, device.  This portable and lightweight device measures body fat using by 
sending a very low frequency current from the electrode on one handle to the electrode 
on the other handle.  You will be asked to stand upright and to grip the handles of the 
device firmly and extend arms out straight in front of your body, parallel to the floor.  
After the first measure is completed, you can relax for 60 seconds, and then a second 
measure will be taken with the hand-held device. Each measure will not take more than 
20 seconds.  This test is included solely for research purposes.  This is a non-invasive, 
safe, and painless procedure.   
Accelerometery & Accelerometer Instructions 
You will receive instructions on the correct use of the acclerometry-based motion 
sensor that we would like you to wear for all waking hours of the 24 hour free-living day, 
except when you are showering and swimming- because this device is not waterproof .  
This device is about the size of a matchbox and will be worn on an elastic belt that will 
be provided to you around your waist.  Although you will not be able to glean any 
information from this device while you wear it, it will be measuring the intensity of 
activity in which you are engaging.  In order to obtain the data, the device must be 
downloaded onto a computer using the necessary software.  
 
Hand-held BIA & Event Log Instructions 
You will receive instructions on the use of the hand-held BIA device to use at home as 
well as instrutions on recording the body fat measures.  Items that will be documented 
in the event log include the following: waking time, time of any food, beverage or 
medicine comsumption,  time of any structured exercise such as running or cycling (if 
you exercise during that day), time of any leisure activites throughout the day such as 
casually walking the dog or activities with friends, activities of daily living such as 
shoveling the snow or mopping the floor, and hand-held BIA body fat measures at the 
four pre-selected times.   
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Free-living Day 
The free-living day should be a typical day for you. Please do not alter your dietary or 
physical activity patterns from your normal or typical daily rountine. 
Hand-held BIA Measures & Event Log Completion 
You will bring home the hand-held BIA device. Within 72 hours of the laboratory visit, 
you will be asked to measure body fat with the hand-held BIA device at specific times of 
the day: 1) immediately upon waking and voiding bladder, 2) immediately after eating 
lunch, 3) right before going to bed, and 4) immediately after exercising (if exercise was 
done during the day).  Additionally, you will be asked to complete an event log during 
the free-living condition.  Items that will be documented include the following:  Waking 
time, time of any food or beverage comsumption,  time of exercise (if they exercise 
during that day), time of any leisure activites throughout the day, and hand-held BIA 
body fat measures at the four pre-selected times.   
 
Lab Visit #2 (approximately 25 minutes in duration) 
Within 48 hours of the free-living day, you will return the hand-held BIA device to the 
laboratory where you will be provided with results from the measures on lab visit #1: 
DEXA and tetrapolar BIA measurements.  You will also be asked to complete a few 
questionnaires.   
Questionnaires 
You will be asked to complete six questionnaires after receiving your DEXA and 
tetrapolar BIA measurements.  If you wish to not receive the results from the DEXA and 
tetrapolar BIA measures, you will not complete the five questionnaires.  These 
questionnaires will include four that you completed on your first visit: the three 
questionnaires assessing your motivation to change your exercise habits, your calorie 
and fat intake, and your weight as well as the questionnaires assessing your satisfaction 
and anxiety with various areas of your body.  Finally, you will be asked to complete a 
questionnaire addressing your reaction to your body fat results. It will take approximetly 
10-15 minutes to complete these surveys, and it is important to take your time with the 
surveys and answer each question honestly and completely. 
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4. RISKS & MINIMIZING RISKS 
 
What risks will I face by participating in this study? 
You will face very minimal risks by participating in this research study.  The main risks 
you face by participating in this research study include risks associated with the body fat 
test (DEXA scan).  While taking part in this study as a participant, as a part of the 
research, you will be exposed to a small amount of radiation during the body fat test.  
The overall effect of radiation on the human body is measured in terms of Roentgen 
equivalents in man, or "rem", which is a unit of uniform whole body exposure.  
Radiation you will be exposed to in this study will amount to 0.00004 rems.  The effects 
on your body of this radiation exposure will be added to your overall lifetime radiation 
risk.  Your lifetime radiation risk includes the background radiation you are exposed to 
naturally like everyone else living on this planet, which is on the average 0.3 rem per 
year.  In terms of radiation a person may get exposed to during medical care, the 
amount you will receive in this study will be small compared to the amount of radiation 
received during a routine chest x-ray, which is 0.01 rem. The risk of harm from radiation 
exposure of this amount is too small to estimate. 
There is also a risk of psychological stress when having your weight, height, waist and 
hip circumference, and body fat measured.  You will have the option of not receiving 
any of this information to reduce this risk of psychological stress.  If you would like this 
information, we will fully explain and interpret all of your results.   
There is a chance that the adhesive used on the tetrapolar BIA electrodes may cause 
some mild skin irritation, in the form of redness, similar to the redness seen after taking 
off a band-aid.  Additionally, you will be asked to shave body hair from the wrist and 
ankle area, where electrodes will be placed, if there is an excessive amount of body hair.  
There is a possiblity that the razor could cause mild skin irritation or a potential cut to 
the skin. 
As with any research study, there may be additional risks of participating that are 
unforeseeable or hard to predict. 
 
 
5. BENEFITS 
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Will I receive any benefit from my participation in this study? 
Yes, we will provide you with information on your bone mineral density and body fat if 
you would like this information. The researcher will not provide any medical diagnosis as 
the result of the study. 
Are subjects paid or given anything for being in the study? 
Extra credit will be offered to students at the discretion of professors.  No monetary 
compensation will be given for participating in the study. 
 
6. STUDY COSTS 
 
Will I be charged anything for participating in this study? 
You will not be responsible for any of the cost associated with participating in this 
research study.  However, you will be responsible for transportation and/or parking fees 
when attending the laboratory visits. 
 
7. CONFIDENTIALITY 
 
What happens to the information collected? 
The information collected in this study is kept strictly confidential.  Only the people 
directly involved in this study will have access to the information.  However, the 
Institutional Review Board at UW-Milwaukee or appropriate federal agencies like the 
Office for Human Research Protections may review your records.  Your name will never 
be associated with any of the information collected.  Your name will be associated with 
an identification number which will not allow your information to be traced back to you.  
We may decide to present what we find to others, or publish our results in scientific 
journals or at scientific conferences.  If this happens, your name will never be associated 
with any of the data collected, and your identity will always remain strictly confidential.  
All research data is stored electronically on a password protected computer as well as in 
hard copy in a locked cabinet.   
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8. ALTERNATIVES 
 
Are there alternatives to participating in the study? 
There are no known alternatives available to you other than not taking part in this 
study. 
9. VOLUNTARY PARTICIPATION & WITHDRAWAL 
 
What happens if I decide not to be in this study? 
Your participation in this study is entirely voluntary. You may choose not to take part in 
this study, or if you decide to take part, you can change your mind later and withdraw 
from the study. You are free to not answer any questions or withdraw at any time. Your 
decision will not change any present or future relationships with the University of 
Wisconsin Milwaukee. The investigator may stop your participation in this study if she 
feels it is necessary to do so or if the results of the pregnancy test confirm a pregnancy. 
 
10. QUESTIONS 
Who do I contact for questions about this study? 
For more information about the study or the study procedures or treatments, or to 
withdraw from the study, contact: 
Ann M. Swartz, Ph.D. 
Associate Professor 
Department of Human Movement Sciences 
University of Wisconsin – Milwaukee 
P.O. Box 413, Milwaukee, WI 53201 
Telephone Number:  (414) 229-4242 
 
Who do I contact for questions about my rights or complaints towards my treatment 
as a research subject? 
The Institutional Review Board may ask your name, but all complaints are kept in 
confidence. 
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Institutional Review Board 
Human Research Protection Program 
Department of University Safety and Assurances 
University of Wisconsin – Milwaukee 
P.O. Box 413 
Milwaukee, WI 53201 
(414) 229-3173 
11. SIGNATURES 
 
Research Subject’s Consent to Participate in Research: 
To voluntarily agree to take part in this study, you must sign on the line below.  If you 
choose to take part in this study, you may withdraw at any time.  You are not giving up 
any of your legal rights by signing this form.  Your signature below indicates that you 
have read or had read to you this entire consent form, including the risks and benefits, 
and have had all of your questions answered, and that you are 18-40 or 50-75 years of 
age. 
_____________________________________________ 
Printed Name of Subject/ Legally Authorized Representative 
_____________________________________________ _____________________ 
Signature of Subject/Legally Authorized Representative Date 
Principal Investigator (or Designee) 
I have given this research subject information on the study that is accurate and sufficient 
for the subject to fully understand the nature, risks and benefits of the study. 
 _____________________________________________________  ________________________  
Printed Name of Person Obtaining Consent Role on Study 
 _____________________________________________________  ________________________  
Signature of Person Obtaining Consent Date 
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HEALTH HISTORY AND 
DEMOGRAPHIC QUESTIONNAIRE 
Name:                
 
Address:             ____________ 
City:            ZipCode:      
 
Phone:         Date of Birth:                 Current Age: ________ 
 
E-mail address: ____________________________________ 
 
Gender (circle one):         M              F  If Female, have you reached menopause? (circle one)  Yes    No 
      If YES, at what age?  ____________ 
Are You Pregnant or Breast Feeding Or Trying To Get Pregnant?           Y         N 
 
Do you currently have any diagnosis of congestive heart failure, cardiomyopathy disease, heart valve  
disease or have a pacemaker? (circle one):    Yes        No 
 
Do you currently have a diagnosis of Cirrhosis, kidney disease or metabolic disease such as diabetes or  
thyroid disease?  (circle one):    Yes        No 
 
Have you been diagnosed with any pulmonary disease such as Chronic Obstructive Pulmonary Disease?    
(circle one):    Yes        No 
 
Occupation:             Full Time? (circle one):    Yes        No 
 
Marital Status (circle one):        Single        Married        Divorced        Widowed 
 
Education (circle highest level completed):   Elementary       High School        College          Graduate School 
 
Race (circle ethnicity):      White        American Indian          Asian           Hispanic    
 
Black / African American    Native Hawaiian / Pacific Islander     
 
Are you taking any prescription or over-the counter medication? (circle one) YES      NO 
If YES, please indicate the names, reasons, and how long you have been taking the medication below. 
Name of Medication    Reason for Taking    For How Long? 
                
                 
                
 
 
 
Physical Activity & Health Research Lab 
Department of Human Movement Sciences 
Enderis Hall, Rm. 434 • (414)229-4392 
PROJECT ID 
    
CURRENT DATE 
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Emergency Contact Information: 
Name:                
Relationship:     Phone:  Work:         
       Home:         
Personal Physician Name:        Location:      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YOUR PAST HEALTH HISTORY 
Circle any of the following medical conditions you 
have either been diagnosed with or have experienced.  
 
High blood pressure             Stroke 
Any heart problems          Blood Clots 
Arthritis            Cancer 
Diabetes 
Recurring leg pain (not related to arthritis) 
Liver or Kidney Disease 
Any breathing or lung problems  
Ankle swelling (not related to twisting) 
Low back or joint problems 
Diabetes 
FAMILY HEALTH HISTORY 
Circle any of the following medical conditions 
experienced by any immediate family  and 
indicate who has/had the condition and when 
(brothers/sisters, children, parents). 
 
Heart attacks            Stroke 
High blood pressure         Early death 
High cholesterol      Diabetes        
Congenital heart defect 
Heart operations   
Other family illnesses                  
       
YOUR PRESENT HEALTH (SIGNS & SYMPTOMS) 
     Circle any of the following signs and symptoms you are currently experiencing (within the last year).  
 
    Chest pain / discomfort    Cough on exertion 
  
    Shortness of breath    Coughing of blood 
 
    Heart palpitations    Dizzy spells 
 
     Skipped heart beats    Frequent headaches 
 
              Heart Attack      Orthopedic / joint problems 
     Diabetes      Back Pain 
     Have you been hospitalized in the last year?(circle one)   Yes     No 
     If YES, how many days were you in hospital?     Have you ever h d your chol sterol measured? (circle one)   YES   NO      If YES, (list value)   
Do you currently smoke? (circle one)  YES     NO                             If YES, what? (circle)  Cigarettes    Cigars       Pipe    
How much per day: (circle one)   < 0.5 pack      0.5 to 1 pack       1.5 to 2 packs       >2 packs   
Have you ever quit smoking? (circle one)    YES      NO          If YES, how old were you when you quit?______                                
How many years did you smoke?    
Do you drink alcoholic beverages? (circle one)  YES     NO              If YES, how many beverages in 1 week?  
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Instructions for free-living day: 
You will be asked to use the hand-held body fat monitor at home throughout the course of one 
free-living day and also to document certain activities on the Free-living Day Log.   
Items that will be documented in the event log include the following: waking time, time of any 
food, beverage or medicine comsumption,  time of any structured exercise such as running or 
cycling (only if you exercise during that day), time of any leisure activites throughout the day 
such as casually walking the dog or activities with friends, activities of daily living such as 
shoveling the snow or mopping the floor, and hand-held BIA body fat measures at the four pre-
selected times.  Directions for use of the hand-held BIA device are below.  Please see the Free-
living Day Log attached. 
Additionally, you will be asked to wear an accelerometer throughout the course of the free-
living day in order to measure the intensity of activity in which you are engaging.  Instructions 
for the accelerometer are found on the back side of this sheet. 
 
Instruction for use of hand-held BIA device: 
1.  Press the yellow (On/Off) button. 
2. Press the white (Up) button until you see the number 1 flashing. 
3. Press the green (Start) button. 
4. You will be asked to stand upright and to grip the handles of the device firmly, thumbs 
pointed up and extend arms out straight in front of your body, parallel to the floor.  See 
photos: 
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5. After the first measure is completed, Press the yellow (On/Off) button. 
6. You can relax for 60 seconds, and then a second measure will be taken with the hand-
held device using the previous five steps.   Each measure will not take more than 20 
seconds. 
 
Instructions for wearing the accelerometer  
 
1. The accelerometer is the red unit.  Please wear during all waking hours of the free-living 
day  
 
2. Wear the accelerometer on your right hip, in line with your right knee cap.  **Please 
make sure that the accelerometer is as vertical as possible (not slanting away from or 
toward your body). 
 
3. Wear the accelerometer for all hours you are awake.  Only remove the accelerometer 
for showering/bathing or swimming and while sleeping.  It is essential that the 
accelerometer stays in a specific orientation with the orange dot facing up. 
 
4. You are not required to record any information, press any buttons, etc. for the 
accelerometer.  Simply wear it as instructed for the free-living day and return on your 
next visit. 
 
 
 
 
 
 
 
 
  
146 
 
APPENDIX F: EVENT LOG 
 
         
147
 
 
Free-living Day Log 
Please use the Omron HBF-306C device to measure body fat at these four specific times. Take two measures, separated by 60 seconds of rest. 
 Time 
(00:00am/pm) 
Measure 1 
(00.0%) 
Measure 2 (00.0%) Describe the 30 minutes prior to the BIA 
measurements.  Please include 
consumption of any food, beverage or 
medication, as well as any structured 
exercise or leisure activity. 
1. Immediately upon 
waking and voiding 
bladder 
   *include consumption of alcohol, caffiene or 
other stimulants of the previous evening. 
2. Immediately after 
eating lunch 
    
3. Right before going to 
bed 
    
4. Immediately after 
exercising (if exercise 
was done during the 
day) 
    
Structured exercise: planned exercise for health benefits such as jogging, cycling, resistance training, etc.  Leisure activity: light activities not done for health 
benefits such as shopping, gardening, or casual walk with a friend. 
Study #:___________ 
Day:______________ 
Date:_____________ 
